<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="publisher">pbio</journal-id><journal-id journal-id-type="flc">plbi</journal-id><journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id><journal-id journal-id-type="pmc">plosbiol</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Biology</journal-title></journal-title-group><issn pub-type="ppub">1544-9173</issn><issn pub-type="epub">1545-7885</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="doi">10.1371/journal.pbio.0050002</article-id><article-id pub-id-type="publisher-id">06-PLBI-RA-0854R3</article-id><article-id pub-id-type="sici">plbi-05-01-01</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Computational Biology</subject>
          <subject>Computational Biology</subject>
          <subject>Diabetes and Endocrinology</subject>
          <subject>Genetics and Genomics</subject>
          <subject>Geriatrics</subject>
        </subj-group>
        <subj-group subj-group-type="System Taxonomy">
          <subject>Mus (mouse)</subject>
          <subject>Mammals</subject>
        </subj-group>
      </article-categories><title-group><article-title>Impaired Genome Maintenance Suppresses the Growth
          Hormone–Insulin-Like Growth Factor 1 Axis in Mice with Cockayne Syndrome</article-title><alt-title alt-title-type="running-head">Premature Ageing
              in<italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> Mice</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
          <name name-style="western">
            <surname>van der Pluijm</surname>
            <given-names>Ingrid</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
          <name name-style="western">
            <surname>Garinis</surname>
            <given-names>George A</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Brandt</surname>
            <given-names>Renata M. C</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Gorgels</surname>
            <given-names>Theo G. M. F</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="fn" rid="n104">
            <sup>¤a</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wijnhoven</surname>
            <given-names>Susan W</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Diderich</surname>
            <given-names>Karin E. M</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>de Wit</surname>
            <given-names>Jan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Mitchell</surname>
            <given-names>James R</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>van Oostrom</surname>
            <given-names>Conny</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Beems</surname>
            <given-names>Rudolf</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Niedernhofer</surname>
            <given-names>Laura J</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="fn" rid="n105">
            <sup>¤b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Velasco</surname>
            <given-names>Susana</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Friedberg</surname>
            <given-names>Errol C</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Tanaka</surname>
            <given-names>Kiyoji</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>van Steeg</surname>
            <given-names>Harry</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Hoeijmakers</surname>
            <given-names>Jan H. J</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>van der Horst</surname>
            <given-names>Gijsbertus T. J</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1">
        <label>1</label><addr-line>
        
       Department of Genetics, Center for Biomedical Genetics, Erasmus University
          Medical Center, Rotterdam, The Netherlands </addr-line></aff><aff id="aff2">
        <label>2</label><addr-line>
        
       National Institute of Public Health and the Environment (RIVM), Laboratory of
          Toxicology, Pathology and Genetics (TOX), Bilthoven, The Netherlands </addr-line></aff><aff id="aff3">
        <label>3</label><addr-line>
        
       Laboratory of Molecular Pathology, Department of Pathology, University of Texas
          Southwestern Medical Center, Dallas, Texas, United States of America </addr-line></aff><aff id="aff4">
        <label>4</label><addr-line>
        
       Division of Cellular Genetics, Institute for Molecular and Cellular Biology,
          Osaka University, Osaka, Japan </addr-line></aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Cooper</surname>
            <given-names>Priscilla</given-names>
          </name>
          <role>Academic Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">Lawrence Berkeley National Lab, United States of America</aff><author-notes>
        <fn fn-type="con" id="ack1">
          <p> IvdP, GAG, JHJH, and GTJvdH conceived and designed
            the experiments. IvdP, GAG, RMCB, TGMFG, SWW, KEMD, JdW, JRM, CvO, RB, SV, HvS, and
            GTJvdH performed the experiments. IvdP, GAG, and GTJvdH analyzed the data. LJN, ECF, KT,
            and HvS, contributed reagents/materials/analysis tools. IvdP, GAG, JHJH, and GTJvdH
            wrote the paper. JHJH is head of the department.</p>
        </fn>
        <fn fn-type="current-aff" id="n104">
          <p>¤a Current address: Department of Molecular Ophthalmology, Netherlands
            Ophthalmic Research Institute, Royal Netherlands Academy of Arts and Sciences,
            Amsterdam, Netherlands</p>
        </fn>
        <corresp id="cor1">* To whom correspondence should be addressed. E-mail: <email xlink:type="simple">g.vanderhorst@erasmusmc.nl</email></corresp>
        <fn fn-type="current-aff" id="n105">
          <p>¤b Current address: University of Pittsburgh Cancer Institute, Pittsburgh,
          Pennsylvania, United States of America</p>
        </fn>
      <fn fn-type="conflict" id="ack3">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="ppub">
        <month>1</month>
        <year>2007</year>
      </pub-date><pub-date pub-type="epub">
        <day>12</day>
        <month>12</month>
        <year>2006</year>
      </pub-date><volume>5</volume><issue>1</issue><elocation-id>e2</elocation-id><history>
        <date date-type="received">
          <day>19</day>
          <month>5</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>10</month>
          <year>2006</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2007</copyright-year><copyright-holder>van der Pluijm et al</copyright-holder><license><license-p>This is an open-access article distributed under
        the terms of the Creative Commons Attribution License, which permits unrestricted use,
        distribution, and reproduction in any medium, provided the original author and source are
        credited.</license-p></license></permissions><related-article issue="11" page="e304" related-article-type="correction-forward" vol="6" xlink:href="info:doi/10.1371/journal.pbio.0060304" xlink:title="Correction" xlink:type="simple">
        <article-title>Correction: Impaired Genome Maintenance Suppresses the Growth Hormone–Insulin-Like Growth Factor 1 Axis in Mice with Cockayne Syndrome</article-title>
      </related-article><abstract>
        <p>Cockayne syndrome (CS) is a photosensitive, DNA repair disorder associated with progeria
          that is caused by a defect in the transcription-coupled repair subpathway of nucleotide
          excision repair (NER). Here, complete inactivation of NER in
              <italic>Csb<sup>m/m</sup></italic>/<italic>Xpa<sup>−/−</sup></italic>
          mutants causes a phenotype that reliably mimics the human progeroid CS syndrome. Newborn
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice display
          attenuated growth, progressive neurological dysfunction, retinal degeneration, cachexia,
          kyphosis, and die before weaning. Mouse liver transcriptome analysis and several
          physiological endpoints revealed systemic suppression of the growth hormone/insulin-like
          growth factor 1 (GH/IGF1) somatotroph axis and oxidative metabolism, increased antioxidant
          responses, and hypoglycemia together with hepatic glycogen and fat accumulation. Broad
          genome-wide parallels between
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and naturally
          aged mouse liver transcriptomes suggested that these changes are intrinsic to natural
          ageing and the DNA repair–deficient mice. Importantly, wild-type mice exposed to
          a low dose of chronic genotoxic stress recapitulated this response, thereby pointing to a
          novel link between genome instability and the age-related decline of the somatotroph
        axis.</p>
      </abstract><abstract abstract-type="toc">
        <p>Studies in mice defective in two DNA repair pathways (global NER and TCR; an animal model
          for Cockayne syndrome) highlight a link between aging, a failure to repair DNA lesions,
          and metabolic alterations.</p>
      </abstract><abstract abstract-type="summary">
        <title>Author Summary</title>
        <sec id="st1">
          <title/>
          <p>Normal metabolism routinely produces reactive oxygen species that damage DNA and other
            cellular components and is thought to contribute to the ageing process. Although DNA
            damage is typically kept in check by a variety of enzymes, several premature ageing
            disorders result from failure to remove damage from active genes. Patients with Cockayne
            syndrome (CS), a genetic mutation affecting one class of DNA repair enzymes, display
            severe growth retardation, neurological symptoms, and signs of premature ageing followed
            by an early death. Whereas mouse models for CS exhibit relatively mild deficits, we show
            that concomitant inactivation of a second DNA repair gene elicits severe CS pathology
            and ageing. Moreover, a few days after birth, these mice undergo systemic suppression of
            genes controlling growth, an unexpected decrease in oxidative metabolism, and an
            increased antioxidant response. Similar physiological changes are also triggered in
            normal mice by chronic exposure to DNA-damaging oxidative stress. From these findings,
            we conclude that DNA damage triggers a response aimed at limiting oxidative DNA damage
            levels (and associated tissue degeneration) to extend lifespan and promote healthy
            ageing. Better understanding of the ageing process will help to delineate intervention
            strategies to combat age-associated pathology.</p>
        </sec>
      </abstract><funding-group><funding-statement>This research was supported by the Netherlands Organization for Scientific Research (NWO)
          through the foundation of the Research Institute Diseases of the Elderly, as well as by
          grants from SenterNovem IOP-Genomics (IGE03009), NIH (1PO1 AG17242–02), NIEHS
          (1UO1 ES011044), EC (QRTL-1999–02002; LSHC-CT-2005–512113), and the
          Dutch Cancer Society (EUR 99–2004). LJN was supported by Postdoctoral Fellowship
          #PF-99–142 from the American Cancer Society. JHJH is CSO of DNage.</funding-statement></funding-group><counts>
        <page-count count="16"/>
      </counts><!--===== Restructure custom-meta-wrap to custom-meta-group =====--><custom-meta-group>
        <custom-meta>
          <meta-name>citation</meta-name>
          <meta-value>van der Pluijm I, Garinis GA, Brandt RMC, Gorgels TGMF, Wijnhoven SW, et al.
            (2007) Impaired genome maintenance suppresses the growth hormone–insulin-like
            growth factor 1 axis in mice with Cockayne syndrome. PLoS Biol 5(1): e2. doi:<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pbio.0050002" xlink:type="simple">10.1371/journal.pbio.0050002</ext-link></meta-value>
        </custom-meta>
      </custom-meta-group></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>A prevailing hypothesis to explain the molecular basis of ageing is Harman's
        “free-radical theory of ageing”, which states that endogenous reactive
        oxygen species (ROS), which result from cellular metabolism, continually damage biomolecules
          [<xref ref-type="bibr" rid="pbio-0050002-b001">1</xref>]. In line with
        this hypothesis, it has been shown that increased resistance to oxidative stress (e.g., by
        improved antioxidant defense) extends the lifespan of <italic>Caenorhabditis elegans,
          Drosophila,</italic> and rodents [<xref ref-type="bibr" rid="pbio-0050002-b002">2</xref>–<xref ref-type="bibr" rid="pbio-0050002-b004">4</xref>],
        whereas hypersensitivity to oxygen considerably reduces the lifespan of nematodes
          [<xref ref-type="bibr" rid="pbio-0050002-b005">5</xref>]. A key
        macromolecule at risk for ROS-mediated damage is nuclear DNA [<xref ref-type="bibr" rid="pbio-0050002-b001">1</xref>], which is evident from the wide range of
        oxidative DNA lesions that accumulate gradually in rodents and humans with advancing age
          [<xref ref-type="bibr" rid="pbio-0050002-b006">6</xref>,<xref ref-type="bibr" rid="pbio-0050002-b007">7</xref>].</p>
      <p>In humans, the causative role of DNA damage in ageing is supported by a variety of
        progeroid disorders with defects in DNA repair pathways [<xref ref-type="bibr" rid="pbio-0050002-b008">8</xref>,<xref ref-type="bibr" rid="pbio-0050002-b009">9</xref>]. One such condition is Cockayne syndrome (CS) (affected genes:
          <italic>CSA</italic> or <italic>CSB</italic>), a photosensitive disorder that originates
        from a defect in transcription-coupled repair (TCR), which specifically removes DNA lesions
        that obstruct RNA polymerases, allowing resumption of transcription and promoting cellular
        survival from DNA damage. TCR of helix-distorting DNA damage is a dedicated subpathway of
        the multi-step “cut-and-patch” nucleotide excision repair (NER) system,
        and is designated TC-NER [<xref ref-type="bibr" rid="pbio-0050002-b010">10</xref>] to distinguish it from the so-called global genome NER (GG-NER)
        subpathway that operates genome-wide to eliminate distorting damage. Available evidence
        suggests that CS cells are also defective in TCR of non–helix distorting DNA
        lesions that block transcription such as transcription-blocking oxidative DNA lesions
          [<xref ref-type="bibr" rid="pbio-0050002-b011">11</xref>,<xref ref-type="bibr" rid="pbio-0050002-b012">12</xref>], which are normally genome-wide removed by
        base excision repair. We will use the term TCR when referring to transcription-coupled
        repair in general.</p>
      <p>CS patients present with growth failure (cachectic dwarfism), progressive neurological
        abnormalities (including delayed psychomotor development, mental retardation, microcephaly,
        gait ataxia, sensorineural hearing loss, retinal degeneration), along with impaired sexual
        development, kyphosis, osteoporosis, and severely reduced lifespan (mean age of death: 12.5
        y) [<xref ref-type="bibr" rid="pbio-0050002-b013">13</xref>,<xref ref-type="bibr" rid="pbio-0050002-b014">14</xref>]. A related yet distinct disorder is
        trichothiodystrophy (TTD) (affected genes: <italic>XPB, XPD,</italic> or
        <italic>TTDA</italic>). TTD patients are partially defective in TCR as well as in the
        GG-NER, and share the symptoms associated with CS. In addition, these patients have a
        partial defect in transcription itself, causing additional symptoms such as ichthyosis and
        brittle hair and nails [<xref ref-type="bibr" rid="pbio-0050002-b015">15</xref>]. Many of the CS and TTD features are progressive and resemble premature
        ageing. Because patients develop some but not all aspects of normal ageing in an accelerated
        manner, CS and TTD are considered “segmental progeroid syndromes”
          [<xref ref-type="bibr" rid="pbio-0050002-b008">8</xref>].</p>
      <p>Mouse mutants for CS-A and CS-B reliably mimic the UV sensitivity of CS patients and show
        accelerated photoreceptor loss, reduced body weight, and mild neurologic abnormalities
          [<xref ref-type="bibr" rid="pbio-0050002-b016">16</xref>,<xref ref-type="bibr" rid="pbio-0050002-b017">17</xref>]. Similarly, mice homozygous for a causative
        TTD point mutation in the <italic>Xpd</italic> gene faithfully mirror the symptoms in TTD
        patients [<xref ref-type="bibr" rid="pbio-0050002-b009">9</xref>], whereas
        complete inactivation of NER (by concurrent inactivation of the <italic>Xpa</italic> gene)
        dramatically aggravates the CS features of partially NER-defective TTD mice [<xref ref-type="bibr" rid="pbio-0050002-b009">9</xref>]. These observations, together
        with the notion that DNA lesions can provoke a permanent cell cycle arrest or apoptosis, led
        us to propose that ageing can result from (oxidative) DNA lesions that interfere with
        transcription and/or replication causing cell death or cellular senescence, ultimately
        leading to the loss of tissue homeostasis and the onset of age-related diseases
          [<xref ref-type="bibr" rid="pbio-0050002-b018">18</xref>–<xref ref-type="bibr" rid="pbio-0050002-b020">20</xref>].</p>
      <p>Here we report that mice with engineered mutations in both <italic>Csb</italic> and
          <italic>Xpa</italic> genes display many CS features in a dramatic form, including
        postnatal growth attenuation, progressive kyphosis, ataxia, retinal degeneration, motor
        dysfunction, and premature death. Importantly, full genome transcriptome analysis of the
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mouse liver at
        the age of 15 d uncovered a systemic response seen also in wild-type (wt) mice exposed to
        chronic oxidative stress. These findings disclose a novel link between DNA damage,
        compromised genome maintenance, and the somatotrophic axis that determines lifespan and shed
        new light on the etiology of Cockayne syndrome and natural ageing.</p>
    </sec>
    <sec id="s2">
      <title>Results</title>
      <sec id="s2a">
        <title>Attenuated Growth and Perinatal Death in
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> Mice</title>
        <p>TCR-defective <italic>Csb<sup>m/m</sup></italic> mutant mice [<xref ref-type="bibr" rid="pbio-0050002-b016">16</xref>] were intercrossed with
          GG-NER-defective <italic>Xpc<sup>−/−</sup></italic> [<xref ref-type="bibr" rid="pbio-0050002-b021">21</xref>] and GG/TC-NER-defective
              <italic>Xpa<sup>−/−</sup></italic> [<xref ref-type="bibr" rid="pbio-0050002-b022">22</xref>] animals to investigate whether an increase
          in the endogenous burden of unrepaired DNA damage, as provoked by the inactivation of
          GG-NER, enhances the phenotype, including progeroid features. Analysis of UV-induced
          repair synthesis and RNA synthesis recovery (indicative for GG-NER and TC-NER capacity,
          respectively) confirmed complete inactivation of NER in
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> animals
            (<xref ref-type="fig" rid="pbio-0050002-g001">Figure 1</xref>A). As expected on the
          basis of previous work, <italic>Xpa<sup>−/−</sup></italic> cells
          display the highest UV sensitivity, whereas
          <italic>Xpc<sup>−/−</sup></italic> and
          <italic>Csb<sup>m/m</sup></italic> cells show intermediate sensitivities
              (<italic>Xpa<sup>−/−</sup></italic> &gt;
            <italic>Csb<sup>m/m</sup></italic> &gt;
            <italic>Xpc<sup>−/−</sup></italic> &gt; wt; see <xref ref-type="fig" rid="pbio-0050002-g001">Figure 1</xref>B). Interestingly, inactivation of
          GG-NER in <italic>Csb<sup>m/m</sup></italic> mouse embryonic fibroblasts (MEFs) (as in
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> cells)
          renders cells more UV-sensitive than already completely NER-deficient
              <italic>Xpa<sup>−/−</sup></italic> MEFs. We attribute this
          enhanced sensitivity to the absence of CSB-mediated TCR of UV-induced lesions that do not
          form a substrate for NER. Thus, the repair defect in the double mutant appears to be more
          severe than that of the single mutants. We could not detect a similar increased
          sensitivity to ionizing radiation in double-mutant cells above that of
            <italic>Csb<sup>m/m</sup></italic> cells [<xref ref-type="bibr" rid="pbio-0050002-b012">12</xref>] (unpublished data), supporting the notion
          that MEFs in culture are already under high oxygen stress [<xref ref-type="bibr" rid="pbio-0050002-b023">23</xref>,<xref ref-type="bibr" rid="pbio-0050002-b024">24</xref>].</p>
        <fig id="pbio-0050002-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.0050002.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Growth Retardation, Cachexia, and Premature Death in
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
                  <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> Mice</title>
            <p>(A) UV repair characteristics of wt, single-mutant, and double-mutant primary MEFs.
              UV-induced UDS (left panel) and recovery of RNA Synthesis (RRS, right panel) are
              indicative for GG-NER and TC-NER capacity, respectively. For a detailed explanation of
              the procedure, see Methods. Error bars indicate standard error of the mean (SEM).</p>
            <p>(B) Survival of primary MEFs exposed to increasing doses of UV-C light (254 nm), as
              determined using the with [<sup>3</sup>H]-thymidine incorporation
              assay. Error bars (in most cases smaller than symbols used) indicate SEM.</p>
            <p>(C) Photograph of a 14-d-old
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mouse
              with an <italic>Xpa<sup>−/−</sup></italic> littermate (hybrid
              129Ola/C57BL/6J background).</p>
            <p>(D) Photograph of an 8-d-old
                  <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> mouse
              with a <italic>Csb<sup>m/m</sup></italic> littermate (hybrid 129Ola/C57BL/6J
              background).</p>
            <p>(E) Body weight curve of
                <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
                  <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> mice
                (<italic>n</italic> = 7) compared to those defective in a single NER gene
                (<italic>n</italic> = 7) all in a hybrid 129Ola/C57BL/6J background. The
              arrow indicates birth. Error bars (in most cases smaller than symbols used) indicate
              SEM.</p>
            <p>(F) Photographs of day 18.5
                <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
                  <italic>Xpa<sup>−/−</sup></italic> embryos (C57BL/6J).</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.g001" xlink:type="simple"/>
        </fig>
        <p>As evident from their overall appearance and weight (<xref ref-type="fig" rid="pbio-0050002-g001">Figure 1</xref>C–<xref ref-type="fig" rid="pbio-0050002-g001">1</xref>E),
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> pups (hybrid
          C57BL/6Jx129ola genetic background) displayed a strikingly attenuated growth, resulting in
          pronounced dwarfism. Whereas the number of double mutant pups was ∼3-fold below
          that expected for Mendelian inheritance (<xref ref-type="supplementary-material" rid="pbio-0050002-st001">Table S1</xref>), embryonic day 18/5 (E18.5)
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> embryos were
          present at Mendelian frequency, pointing to considerable lethality during or shortly after
          birth. Importantly, double-mutant embryos were morphologically and histologically
          indistinguishable from wt and single-mutant embryos (<xref ref-type="fig" rid="pbio-0050002-g001">Figure 1</xref>F and unpublished data), indicating that the
          growth defect was postnatal and did not reflect impaired embryonic development per se. In
          the third week of life, however,
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> pups
          developed progressive cachexia (evident from the weight loss after day 15; see <xref ref-type="fig" rid="pbio-0050002-g001">Figure 1</xref>E), ultimately resulting in death
          before postnatal day 22. Neither moistening of food pellets (to facilitate intake of
          solids) nor removal of wt or single-mutant pups from the litter (to reduce competition for
          breast milk) improved the physical condition or the lifespan of
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> pups.
          Necropsy revealed milk or solid food in the stomach, indicating that insufficient access
          to supplied nutrition was not the underlying cause of growth retardation, weight loss, and
          early death. Importantly, progressive growth retardation, cachexia, and short life
          expectation (∼12.5 y) are also observed in human patients with CS [<xref ref-type="bibr" rid="pbio-0050002-b013">13</xref>]. Combined inactivation of
            <italic>Xpa</italic> and <italic>Xpc</italic> rendered mice without any overt phenotype
          (unpublished data), leading us to conclude that the dramatic phenotype of
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> pups results
          from a combined GG-NER/TC-NER/TCR defect.</p>
      </sec>
      <sec id="s2b">
        <title>Growth and Neurological Abnormalities in
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> Mice</title>
        <p>Further analysis of the
          <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> phenotype,
          performed in an isogenic C57BL/6J background, revealed a near-normal size of the skull at
          day 11 and 21 (autoradiographs shown in <xref ref-type="fig" rid="pbio-0050002-g002">Figure 2</xref>A), implying that the (postnatal) growth defect is restricted to the
          trunk, and to a lesser extent, the extremities. All 21-d-old double-mutant animals showed
          kyphosis (abnormal curvature of the spinal column, <xref ref-type="fig" rid="pbio-0050002-g002">Figure 2</xref>A, middle left and bottom right), which was also
          observed in younger
          <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups, indicating
          that it is not determined by terminal illness. The normal appearance of the spine in
          11-d-old double-mutant pups excluded a prenatal developmental defect and further pointed
          to an extremely accelerated onset of kyphosis, a feature observed in naturally aged (2-y
          old) C57BL/6J mice (see <xref ref-type="fig" rid="pbio-0050002-g002">Figure 2</xref>A,
          bottom left panel). Two-dimensional images of proximal end-to-mid-diaphysis
          micro–computed tomography (micro-CT) scans of fixed tibiae from 10-, 15-, and
          20-d-old wt and <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic>
          mice revealed retarded, yet steady, longitudinal as well as radial (perimeter) growth,
          along with a thinner bone cortex and a less developed growth plate (<xref ref-type="fig" rid="pbio-0050002-g002">Figure 2</xref>B). In line with this observation, we observed a
          reduction in tibia length (<xref ref-type="fig" rid="pbio-0050002-g002">Figure 2</xref>C).
          Notably, whereas <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic>
          pups lose weight in the third week of life, bone growth proceeds, resulting in relatively
          large extremities, a representative feature of CS and TTD [<xref ref-type="bibr" rid="pbio-0050002-b013">13</xref>].</p>
        <fig id="pbio-0050002-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.0050002.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Skeletal and Neurological Abnormalities in
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> Mice</title>
            <p>(A) Radiographs of wt and
                <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice (age
              as indicated) and photograph of a 15-d-old
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mouse
              (C57BL/6J).</p>
            <p>(B) 2-D images of micro-CT scans of tibiae taken from
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> animals
              and wt littermate controls (age indicated in the figure). Horizontal sections are
              shown of the upper and lower part of the tibiae. e, epiphysis; g, growth plate; and d,
              diaphysis. I indicates the section through the smaller part of the diaphysis, II
              indicates section through the broader part of the diaphysis.</p>
            <p>(C) Growth of tibiae, taken from
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> animals
              (light squares) and wt littermate controls (dark squares).</p>
            <p>(D) Representative footprint patterns of 19-d-old wt and
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice.
              Arrows indicate the trajectory of each mouse. Stride length and front base width
              measurements on 15-d-old wt, <italic>Xpa<sup>−/−</sup>,
                  Csb<sup>m/m</sup>,</italic> and
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice. The
              significantly (asterisk; <italic>p</italic> &lt; 0.001) greater base width in the
              double mutant mouse indicates ataxia.</p>
            <p>(E) Representative pictures of a TUNEL staining in the retina of wt and
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice and
              quantification of the number of TUNEL positive cells. Arrows indicate TUNEL positive
              cells in the ONL and INL. Note the significantly higher number of TUNEL-positive cells
              in both the ONL and the INL in the retina of
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> compared
              to wt mice (asterisk; <italic>p</italic> &lt; 0.05).</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.g002" xlink:type="simple"/>
        </fig>
        <p>Motor coordination problems, manifesting as tremors and abnormal posture of the hind
          limbs (flexion rather than extension in tail suspension test), became evident around day
          10 in <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice
          (unpublished data). Foot print analysis revealed a disturbed gait from day 15 onwards.
          Whereas wt and single-mutant animals maintained a straight path with regular alternating
          strides, <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice
          demonstrated a nonuniform alternating left-right step pattern and unevenly spaced shorter
          strides (<xref ref-type="fig" rid="pbio-0050002-g002">Figure 2</xref>D). Despite their
          runted size, the front base width of
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> animals was
          significantly greater than that of wt and single-mutant littermates, which likely
          illustrates an attempt to maintain balance (<xref ref-type="fig" rid="pbio-0050002-g002">Figure 2</xref>D). These data are consistent with the profound early postnatal ataxia
          and abnormal cerebellar development in
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice
            [<xref ref-type="bibr" rid="pbio-0050002-b025">25</xref>] and the
          progressive neurodegeneration observed in human CS patients [<xref ref-type="bibr" rid="pbio-0050002-b026">26</xref>].</p>
        <p>We next examined the retinas of 15-d-old
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups for the
          presence of apoptotic cells, because retinal degeneration is a prominent neurological
          feature of CS patients [<xref ref-type="bibr" rid="pbio-0050002-b027">27</xref>] and adult CS mice (T. Gorgels, I. van der Pluijm, R. Brandt, G.
          Garinis, H. van Steeg, et al., unpublished data). At this age, cell loss occurs as part of
          the normal development of the retina. Yet, as shown by terminal
          deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) (<xref ref-type="fig" rid="pbio-0050002-g002">Figure 2</xref>E) and caspase-3 staining (unpublished data), the
          number of apoptotic cells in the outer nuclear layer (ONL) and inner nuclear layer (INL)
          of the retinas of <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic>
          pups was significantly increased (analysis of variance [ANOVA], S-N-K
          posthoc test, <italic>p</italic> &lt; 0.05), as compared to wt and single-mutant
          littermates (<xref ref-type="fig" rid="pbio-0050002-g002">Figure 2</xref>E). Thus, the
            <italic>Xpa</italic> defect enhanced the apoptotic sensitivity of photoreceptor cells in
              <italic>Csb<sup>m/m</sup></italic> mice, thereby pointing to DNA damage as a trigger
          for age-related retinal degeneration. Because 15-d-old <italic>Csb<sup>m/m</sup></italic>
          mice still have wt levels of apoptotic cells, spontaneous photoreceptor loss in the
              <italic>Csb<sup>m/m</sup></italic> mouse initiates in the second/third month of life.</p>
        <p>Visual inspection and histological analysis of most internal organs of 15-d-old
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice did not
          reveal any obvious pathological abnormalities (unpublished data), with the exception of
          substantial loss of abdominal fat. Because we did not find any sign of infections,
          necrosis, or abnormal cellular proliferation (as determined by bromodeoxyuridine
          [BrdU] staining) in the gastrointestinal tract of 15- and 21-d-old
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> animals,
          intestinal malfunction is an unlikely cause of the growth defect (<xref ref-type="fig" rid="pbio-0050002-g003">Figure 3</xref>A). In addition, the liver had a normal
          histological appearance (<xref ref-type="fig" rid="pbio-0050002-g003">Figure 3</xref>B),
          whereas neither BrdU (<xref ref-type="fig" rid="pbio-0050002-g003">Figure 3</xref>C),
          proliferating cell nuclear antigen (PCNA) (<xref ref-type="fig" rid="pbio-0050002-g003">Figure 3</xref>D), and Ki67 staining (unpublished data), nor TUNEL (<xref ref-type="fig" rid="pbio-0050002-g003">Figure 3</xref>E) and caspase-3 staining
          (unpublished data) revealed any significant difference between
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and wt
          livers. This finding indicates that aberrant cell proliferation or apoptosis in the liver
          does not likely contribute to the
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> phenotype.
          Moreover, inactivation of the <italic>p53</italic> tumor-suppressor gene failed to rescue
          the mutant phenotype, because
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup>/p53<sup>−/−</sup></italic>
          triple-mutant pups appeared indistinguishable from
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups
          (unpublished data). Thus, the precise etiology of the overall physical deterioration and
          the cause of death of
          <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice remain
          unknown.</p>
        <fig id="pbio-0050002-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.0050002.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Histological Examination of
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> Tissues</title>
            <p>(A) BrdU staining of the jejunum of
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              littermate control mice, showing normal proliferative capacity of the intestine in the
              double mutant mouse. (B–E) Histological examination of liver sections of
              15-d-old <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              littermate control mice, stained with HE (B), immunostained for the proliferation
              markers (incorporated) BrdU (C) and PCNA protein (D), or TUNEL-stained for the
              presence of apoptotic cells (E). Quantification of the number of proliferative or
              apoptotic cells did not reveal significant differences between
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and wt
              littermate mice. (F) HE staining of the pituitary of
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              littermate control mice.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.g003" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s2c">
        <title>Enhanced Ionizing Radiation Sensitivity of the
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> Mouse Retina</title>
        <p>The spontaneous, age-related and ionizing radiation (IR)–induced loss of
          post-mitotic photoreceptor cells in <italic>Csb<sup>m/m</sup></italic> mice underscores
          the relevance of DNA repair in the removal of (oxidative) DNA damage for the long-term
          survival of terminally differentiated cells in the retina (T. Gorgels, I. van der Pluijm,
          R. Brandt, G. Garinis, H. van Steeg, et al., unpublished data). To test whether
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> animals are
          more sensitive to genotoxic insults than are single-mutant
          <italic>Csb<sup>m/m</sup></italic> and
          <italic>Xpa<sup>−/−</sup></italic> animals, we next examined if the
          additional <italic>Xpa</italic> defect further enhances the IR sensitivity of the
              <italic>Csb<sup>m/m</sup></italic> retina. To this end, we exposed 18-d-old
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups and wt
          and single-mutant littermates to γ rays (10 Gy) and quantified the number of
          apoptotic cells in the retina by TUNEL staining 20 h after exposure. As shown in <xref ref-type="fig" rid="pbio-0050002-g004">Figure 4</xref>, the number of apoptotic cells in
          the ONL of untreated (19-d-old)
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups further
          increased, as compared to 15-d-old double-mutant animals (see <xref ref-type="fig" rid="pbio-0050002-g002">Figure 2</xref>E). Whereas IR exposure did not increase the
          frequency of apoptotic photoreceptors in the ONL of wt and
              <italic>Xpa<sup>−/−</sup></italic> animals,
            <italic>Csb<sup>m/m</sup></italic> mice already show a tendency to increased
          photoreceptor loss, as characteristic for mature <italic>Csb<sup>m/m</sup></italic>
          animals (T. Gorgels, I. van der Pluijm, R. Brandt, G. Garinis, H. van Steeg, et al.,
          unpublished data). In contrast, the retinas of IR-exposed
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> animals
          showed an almost 2-fold increase in the level of TUNEL-positive photoreceptor cells
          (Student's <italic>t</italic>-test; <italic>p</italic> = 0.021). Taken
          together, these findings not only further point to unrepaired DNA damage (likely
          originating from oxidative stress) as the underlying trigger for photoreceptor loss, but
          importantly, also show that inactivation of <italic>Xpa</italic> further enhances the
          sensitivity of <italic>Csb<sup>m/m</sup></italic> mice to genotoxic stress.</p>
        <fig id="pbio-0050002-g004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.0050002.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>Enhanced Sensitivity of
                <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> Retinal
              Photoreceptor Cells to Genotoxic Insults</title>
            <p>Representative pictures of TUNEL stained retinas of 19-d-old wt,
                <italic>Csb<sup>m/</sup></italic><sup>m</sup><italic>,
                  Xpa<sup>−/−</sup>,</italic> and
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice
              (right panel), 20 h after exposure of animals to 10 Gy of ionizing radiation, and
              quantification of the number of TUNEL positive cells in the ONL (left panel). Note the
              significantly higher number of TUNEL-positive cells in the retina of
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice, as
              compared to wt and single-mutant littermate controls (<italic>p</italic> &lt;
              0.05). Single asterisks indicate statistically significant differences between
              unirradiated <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic>
              and littermate control mice (<italic>p</italic> &lt; 0.05), double asterisks
              indicate statistically significant differences between unirradiated and irradiated
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice
                (<italic>p</italic> &lt; 0.05).</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.g004" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s2d">
        <title>Analysis of the
          <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> Mouse Liver
          Transcriptome</title>
        <p>To investigate whether a disturbance in growth and metabolism could explain the
          pronounced accelerated organismal deterioration seen in
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice, we
          evaluated the liver transcriptome of 15-d-old wt, single-mutant, and double-mutant mice
            (<italic>n</italic> = 4 mice). At this age, the
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups have not
          yet become cachectic. Two-tailed <italic>t</italic> test analysis Affymetrix full mouse
          genome arrays revealed 1,865 genes with significantly changed expression patterns between
          wt and <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> livers
            (<italic>p</italic>
          <bold>≤</bold> 0.01, 1.2-fold change up- or down-regulated, <xref ref-type="supplementary-material" rid="pbio-0050002-st002">Table S2</xref>), a number
          that significantly exceeds the ∼80 genes that are expected to occur by chance
          under these selection criteria. Among the set of 1,865 genes, we identified those gene
          ontology (GO)–classified biological processes with a significantly
          disproportionate number of responsive genes relative to those printed on microarrays
          (false detection rate ≤ 0.10). This unbiased approach revealed processes implicated
          in the derivation of energy from oxidation of organic compounds, homeostasis of energy
          reserves, cell growth and maintenance, and the redox status of the cell.</p>
        <p>Subsequent analysis of these processes led us to identify the following four results.</p>
        <p>(1) A profound attenuation of the somatotroph axis, as evidenced by the consistent
          down-regulation of genes encoding main components of the GH/IGF1 axis (e.g.,
          <italic>IGF1</italic>, <italic>Igfbp3, Igfbp4, Igfals, Ghr</italic>), as well as
          lactotroph (e.g., <italic>Prlr</italic>) and thyrotroph functions (e.g.,
          <italic>Dio1</italic>) in
          <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> livers, in
          addition to a decrease in the expression of several genes associated with a variety of
          mitogenic signals (e.g., <italic>Esr1, Fgf1, Fgfr3, Fgfr4</italic>) (<xref ref-type="table" rid="pbio-0050002-t001">Table 1</xref> and <xref ref-type="supplementary-material" rid="pbio-0050002-st002">Table S2</xref>).</p>
        <table-wrap content-type="2col" id="pbio-0050002-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.0050002.t001</object-id><label>Table 1</label><caption>
            <p>Significant Gene Expression Changes in the Livers of
                  <italic>Csb<sup>m/m</sup>Xpa<sup>−/−</sup>,
              Csb<sup>m/m</sup>,</italic> and <italic>Xpa<sup>−/−</sup></italic>
              Mice Compared to Livers from Littermate Controls</p>
          </caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.t001" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb1col1" align="left" charoff="0" char=""/><col id="tb1col2" align="left" charoff="0" char=""/><col id="tb1col3" align="left" charoff="0" char=""/><col id="tb1col4" align="left" charoff="0" char=""/><col id="tb1col5" align="char" charoff="0" char="."/><col id="tb1col6" align="char" charoff="0" char="."/><col id="tb1col7" align="char" charoff="0" char="."/><col id="tb1col8" align="char" charoff="0" char="."/><col id="tb1col9" align="char" charoff="0" char="."/><col id="tb1col10" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left"><hr/></td><td><hr/></td><td><hr/></td><td><hr/></td><td colspan="2"><hr/><italic>Csb<sup>m/m</sup>Xpa<sup>&minus;/&minus;</sup></italic></td><td colspan="2"><hr/><italic>Xpa<sup>&minus;/&minus;</sup></italic></td><td colspan="2"><hr/><italic>Csb<sup>m/m</sup></italic></td></tr><tr><td><hr/>Process</td><td><hr/>Code</td><td><hr/>Title</td><td><hr/>Symbol</td><td><hr/>FC </td><td><hr/><italic>p</italic>- value</td><td><hr/>FC </td><td><hr/><italic>p-</italic> value</td><td><hr/>FC</td><td><hr/><italic>p</italic>- value</td></tr></thead><tbody><tr><td><bold>The IGF-1/GH growth axis</bold></td><td>1448556_at</td><td>prolactin receptor</td><td>Prlr</td><td>&minus;2.03</td><td>0.000</td><td>&minus;1.25</td><td>0.10</td><td>&minus;1.10</td><td>0.66</td></tr><tr><td></td><td>1419519_at</td><td>insulin-like growth factor 1</td><td>Igf1</td><td>&minus;2.13</td><td>0.000</td><td>&minus;1.08</td><td>0.16</td><td>&minus;1.13</td><td>0.19</td></tr><tr><td></td><td>1421991_a_at</td><td>IGF-binding protein 4</td><td>Igfbp4</td><td>&minus;1.74</td><td>0.000</td><td>&minus;1.07</td><td>0.82</td><td>&minus;1.16</td><td>0.39</td></tr><tr><td></td><td>1458268_s_at</td><td>IGF-binding protein 3</td><td>Igfbp3</td><td>&minus;1.44</td><td>0.001</td><td>&minus;1.10</td><td>0.25</td><td>1.06</td><td>0.59</td></tr><tr><td></td><td>1422826_at</td><td>IGF&minus;binding protein, acid labile subunit</td><td>Igfals</td><td>&minus;2.36</td><td>0.000</td><td>1.06</td><td>0.53</td><td>1.13</td><td>0.26</td></tr><tr><td></td><td>1417962_s_at</td><td>growth hormone receptor</td><td>Ghr</td><td>&minus;1.53</td><td>0.000</td><td>1.03</td><td>0.15</td><td>1.10</td><td>0.05</td></tr><tr><td></td><td>1425458_a_at</td><td>growth factor receptor bound protein 10</td><td>Grb10</td><td>1.84</td><td>0.000</td><td>1.11</td><td>0.59</td><td>1.24</td><td>0.19</td></tr><tr><td></td><td>1427777_x_at</td><td>fibroblast growth factor receptor 4</td><td>Fgfr4</td><td>&minus;1.32</td><td>0.009</td><td>&minus;1.12</td><td>0.71</td><td>&minus;1.19</td><td>0.11</td></tr><tr><td></td><td>1421841_at</td><td>fibroblast growth factor receptor 3</td><td>Fgfr3</td><td>&minus;1.43</td><td>0.001</td><td>&minus;1.32</td><td>0.03</td><td>&minus;1.12</td><td>0.87</td></tr><tr><td></td><td>1450869_at</td><td>fibroblast growth factor 1</td><td>Fgf1</td><td>&minus;1.38</td><td>0.003</td><td>&minus;1.20</td><td>0.09</td><td>&minus;1.01</td><td>0.84</td></tr><tr><td></td><td>1435663_at</td><td>estrogen receptor 1 (alpha)</td><td>Esr1</td><td>&minus;1.91</td><td>0.001</td><td>&minus;1.12</td><td>0.32</td><td>&minus;1.31</td><td>0.12</td></tr><tr><td></td><td>1417991_at</td><td>deiodinase, iodothyronine, type I</td><td>Dio1</td><td>&minus;2.12</td><td>0.000</td><td>1.00</td><td>0.28</td><td>&minus;1.04</td><td>0.28</td></tr><tr><td><bold>Carbohydrate metabolism</bold></td><td>1423644_at</td><td>aconitase 1</td><td>Aco1</td><td>&minus;1.26</td><td>0.002</td><td>1.05</td><td>0.50</td><td>&minus;1.00</td><td>0.96</td></tr><tr><td></td><td>1422577_at</td><td>citrate synthase</td><td>Cs</td><td>&minus;1.28</td><td>0.006</td><td>1.16</td><td>0.20</td><td>&minus;1.03</td><td>0.20</td></tr><tr><td></td><td>1419146_a_at</td><td>glucokinase</td><td>Gck</td><td>&minus;6.59</td><td>0.004</td><td>1.16</td><td>0.28</td><td>&minus;1.01</td><td>0.66</td></tr><tr><td></td><td>1424815_at</td><td>glycogen synthase 2</td><td>Gys2</td><td>1.78</td><td>0.000</td><td>&minus;1.03</td><td>0.22</td><td>&minus;1.01</td><td>0.30</td></tr><tr><td></td><td>1459522_s_at</td><td>glycogenin 1</td><td>Gyg1</td><td>1.26</td><td>0.014</td><td>1.05</td><td>0.15</td><td>1.03</td><td>0.36</td></tr><tr><td></td><td>1417741_at</td><td>liver glycogen phosphorylase</td><td>Pygl</td><td>&minus;1.42</td><td>0.000</td><td>1.02</td><td>0.50</td><td>1.06</td><td>0.03</td></tr><tr><td><bold>Steroid metabolism and biosynthesis</bold></td><td>1417871_at</td><td>hydroxysteroid (17-beta) dehydrogenase 7</td><td>Hsd17b7</td><td>&minus;1.50</td><td>0.000</td><td>&minus;1.33</td><td>0.14</td><td>&minus;1.32</td><td>0.13</td></tr><tr><td></td><td>1449038_at</td><td>hydroxysteroid 11-beta dehydrogenase 1</td><td>Hsd11b1</td><td>&minus;1.32</td><td>0.001</td><td>1.10</td><td>0.34</td><td>1.01</td><td>0.71</td></tr><tr><td></td><td>1460192_at</td><td>oxysterol binding protein-like 1A</td><td>Osbpl1a</td><td>&minus;1.38</td><td>0.000</td><td>&minus;1.10</td><td>0.50</td><td>&minus;1.08</td><td>0.52</td></tr><tr><td></td><td>1427345_a_at</td><td>sulfotransferase family 1A, member 1</td><td>Sult1a1</td><td>&minus;1.29</td><td>0.002</td><td>&minus;1.05</td><td>0.69</td><td>&minus;1.05</td><td>0.59</td></tr><tr><td></td><td>1419528_at</td><td>sulfotransferase, hydroxysteroid preferring 2</td><td>Sth2</td><td>&minus;1.61</td><td>0.000</td><td>&minus;1.08</td><td>0.92</td><td>&minus;1.20</td><td>0.26</td></tr><tr><td><bold>Cytochrome (Cyt) P450, NADH- and NADPH- dependent oxidative metabolism</bold></td><td>1418821_at</td><td>Cyt. P450, family 2, subfam. a, polyp. 12</td><td>Cyp2a12</td><td>&minus;1.51</td><td>0.000</td><td>1.06</td><td>0.21</td><td>&minus;1.06</td><td>0.33</td></tr><tr><td></td><td>1422257_s_at</td><td>Cyt. P450, family 2, subfam. b, polyp. 10</td><td>Cyp2b10</td><td>&minus;2.81</td><td>0.001</td><td>&minus;1.40</td><td>0.75</td><td>&minus;1.39</td><td>0.75</td></tr><tr><td></td><td>1449479_at</td><td>Cyt. P450, family 2, subfam. b, polyp. 13</td><td>Cyp2b13</td><td>&minus;2.24</td><td>0.002</td><td>&minus;1.19</td><td>0.77</td><td>&minus;1.27</td><td>0.98</td></tr><tr><td></td><td>1425645_s_at</td><td>Cyt. P450, family 2, subfam. b, polyp. 20</td><td>Cyp2b20</td><td>&minus;2.94</td><td>0.001</td><td>&minus;1.29</td><td>0.95</td><td>&minus;1.42</td><td>0.36</td></tr><tr><td></td><td>1419590_at</td><td>Cyt. P450, family 2, subfam. b, polyp. 9</td><td>Cyp2b9</td><td>&minus;1.55</td><td>0.000</td><td>&minus;1.06</td><td>0.78</td><td>&minus;1.04</td><td>0.49</td></tr><tr><td></td><td>1417651_at</td><td>Cyt. P450, family 2, subfam. c, polyp. 29</td><td>Cyp2c29</td><td>&minus;1.59</td><td>0.004</td><td>&minus;1.37</td><td>0.09</td><td>&minus;1.41</td><td>0.09</td></tr><tr><td></td><td>1440327_at</td><td>Cyt. P450, family 2, subfam. c, polyp. 70</td><td>Cyp2c70</td><td>&minus;2.58</td><td>0.001</td><td>&minus;1.17</td><td>0.15</td><td>&minus;1.23</td><td>0.58</td></tr><tr><td></td><td>1448792_a_at</td><td>Cyt. P450, family 2, subfam. f, polyp. 2</td><td>Cyp2f2</td><td>&minus;2.36</td><td>0.001</td><td>1.76</td><td>0.05</td><td>1.30</td><td>0.43</td></tr><tr><td></td><td>1417532_at</td><td>Cyt. P450, family 2, subfam. j, polyp. 5</td><td>Cyp2j5</td><td>&minus;3.08</td><td>0.000</td><td>&minus;1.47</td><td>0.10</td><td>&minus;1.31</td><td>0.36</td></tr><tr><td></td><td>1418767_at</td><td>Cyt. P450, family 4, subfam. f, polyp. 13</td><td>Cyp4f13</td><td>&minus;1.67</td><td>0.008</td><td>&minus;1.11</td><td>0.46</td><td>&minus;1.40</td><td>0.36</td></tr><tr><td></td><td>1419559_at</td><td>Cyt. P450, family 4, subfam. f, polyp. 14</td><td>Cyp4f14</td><td>&minus;3.58</td><td>0.000</td><td>1.57</td><td>0.06</td><td>&minus;1.00</td><td>0.92</td></tr><tr><td></td><td>1417070_at</td><td>Cyt. P450, family 4, subfam. v, polyp. 3</td><td>Cyp4v3</td><td>&minus;1.41</td><td>0.001</td><td>1.04</td><td>0.40</td><td>&minus;1.09</td><td>0.81</td></tr><tr><td></td><td>1422100_at</td><td>Cyt. P450, family 7, subfam. a, polyp. 1</td><td>Cyp7a1</td><td>&minus;2.36</td><td>0.006</td><td>1.14</td><td>0.86</td><td>&minus;1.39</td><td>0.24</td></tr><tr><td></td><td>1417429_at</td><td>flavin containing monooxygenase 1</td><td>Fmo1</td><td>&minus;1.38</td><td>0.000</td><td>1.04</td><td>0.23</td><td>1.00</td><td>0.57</td></tr><tr><td></td><td>1422904_at</td><td>flavin containing monooxygenase 2</td><td>Fmo2</td><td>&minus;4.51</td><td>0.008</td><td>&minus;2.17</td><td>0.40</td><td>&minus;2.05</td><td>0.49</td></tr><tr><td></td><td>1449525_at</td><td>flavin containing monooxygenase 3</td><td>Fmo3</td><td>&minus;14.19</td><td>0.004</td><td>&minus;2.03</td><td>0.84</td><td>&minus;2.34</td><td>0.59</td></tr><tr><td></td><td>1423908_at</td><td>NADH dehydrogenase (ubiquinone) Fe-S protein 8</td><td>Ndufs8</td><td>&minus;1.23</td><td>0.002</td><td>1.02</td><td>0.87</td><td>&minus;1.04</td><td>0.13</td></tr><tr><td><bold>Antioxidant and detoxification response</bold></td><td>1422438_at</td><td>epoxide hydrolase 1, microsomal</td><td>Ephx1</td><td>2.10</td><td>0.000</td><td>1.14</td><td>0.30</td><td>&minus;1.12</td><td>0.02</td></tr><tr><td></td><td>1421816_at</td><td>glutathione reductase 1</td><td>Gsr</td><td>1.20</td><td>0.009</td><td>1.19</td><td>0.18</td><td>&minus;1.01</td><td>0.95</td></tr><tr><td></td><td>1421041_s_at</td><td>glutathione S-transferase, alpha 2 (Yc2)</td><td>Gsta2</td><td>1.90</td><td>0.003</td><td>&minus;1.18</td><td>0.09</td><td>&minus;1.59</td><td>0.51</td></tr><tr><td></td><td>1416842_at</td><td>glutathione S-transferase, mu 5</td><td>Gstm5</td><td>1.29</td><td>0.000</td><td>1.02</td><td>0.82</td><td>&minus;1.02</td><td>0.34</td></tr><tr><td></td><td>1449575_a_at</td><td>glutathione S-transferase, pi 2</td><td>Gstp2</td><td>1.40</td><td>0.000</td><td>1.07</td><td>0.64</td><td>1.07</td><td>0.69</td></tr><tr><td></td><td>1417883_at</td><td>glutathione S-transferase, theta 2</td><td>Gstt2</td><td>2.76</td><td>0.000</td><td>1.18</td><td>0.13</td><td>&minus;1.30</td><td>0.05</td></tr><tr><td></td><td>1448239_at</td><td>heme oxygenase (decycling) 1</td><td>Hmox1</td><td>2.43</td><td>0.000</td><td>&minus;1.48</td><td>0.04</td><td>&minus;1.17</td><td>0.12</td></tr><tr><td></td><td>1452592_at</td><td>microsomal glutathione S-transferase 2</td><td>Mgst2</td><td>2.89</td><td>0.000</td><td>1.02</td><td>0.29</td><td>1.10</td><td>0.29</td></tr><tr><td></td><td>1448300_at</td><td>microsomal glutathione S-transferase 3</td><td>Mgst3</td><td>1.49</td><td>0.001</td><td>1.29</td><td>0.04</td><td>1.02</td><td>0.10</td></tr><tr><td></td><td>1430979_a_at</td><td>peroxiredoxin 2</td><td>Prdx2</td><td>1.61</td><td>0.001</td><td>1.75</td><td>0.01</td><td>1.34</td><td>0.26</td></tr><tr><td></td><td>1416292_at</td><td>peroxiredoxin 3</td><td>Prdx3</td><td>1.27</td><td>0.010</td><td>1.24</td><td>0.19</td><td>1.09</td><td>0.18</td></tr><tr><td></td><td>1451124_at</td><td>superoxide dismutase 1, soluble</td><td>Sod1</td><td>1.22</td><td>0.003</td><td>1.26</td><td>0.03</td><td>1.16</td><td>0.10</td></tr><tr><td></td><td>1415996_at</td><td>thioredoxin interacting protein</td><td>Txnip</td><td>2.11</td><td>0.008</td><td>1.05</td><td>0.49</td><td>1.05</td><td>0.42</td></tr><tr><td></td><td>1440221_at</td><td>thioredoxin-like</td><td>Txnl</td><td>1.50</td><td>0.002</td><td>1.26</td><td>0.58</td><td>1.17</td><td>0.83</td></tr><tr><td><bold>Peroxisomal biogenesis</bold></td><td>1416679_at</td><td>ATP-binding cassette, sub-family D member 3</td><td>Abcd3</td><td>&minus;1.29</td><td>0.000</td><td>1.03</td><td>0.63</td><td>1.03</td><td>0.60</td></tr><tr><td></td><td>1449442_at</td><td>peroxisomal biogenesis factor 11a</td><td>Pex11a</td><td>&minus;1.78</td><td>0.010</td><td>&minus;1.97</td><td>0.04</td><td>&minus;1.60</td><td>0.37</td></tr><tr><td></td><td>1451213_at</td><td>peroxisomal biogenesis factor 11b</td><td>Pex11b</td><td>&minus;1.24</td><td>0.010</td><td>&minus;1.03</td><td>0.82</td><td>&minus;1.05</td><td>0.69</td></tr><tr><td><bold>Fatty acid biosynthesis and elongation</bold></td><td>1455994_x_at</td><td>ELOVL1 long chain fatty acid elongatiion</td><td>Elovl1</td><td>1.28</td><td>0.001</td><td>1.24</td><td>0.03</td><td>1.22</td><td>0.08</td></tr><tr><td></td><td>1417403_at</td><td>ELOVL6, long chain fatty acid elongatiion</td><td>Elovl6</td><td>1.37</td><td>0.001</td><td>1.18</td><td>0.23</td><td>1.09</td><td>0.38</td></tr><tr><td></td><td>1415823_at</td><td>stearoyl-Coenzyme A desaturase 2</td><td>Scd2</td><td>1.39</td><td>0.001</td><td>1.29</td><td>0.15</td><td>1.23</td><td>0.45</td></tr><tr><td></td><td>1424119_at</td><td>protein kinase beta 1 non-catalytic subunit</td><td>Prkab1</td><td>1.44</td><td>0.000</td><td>1.28</td><td>0.15</td><td>1.11</td><td>0.80</td></tr><tr><td></td><td>1418438_at</td><td>fatty acid binding protein 2, intestinal</td><td>Fabp2</td><td>1.40</td><td>0.001</td><td>1.09</td><td>0.21</td><td>1.13</td><td>0.03</td></tr><tr><td></td><td>1416021_a_at</td><td>fatty acid binding protein 5, epidermal</td><td>Fabp5</td><td>1.63</td><td>0.000</td><td>&minus;1.19</td><td>0.17</td><td>1.14</td><td>0.57</td></tr><tr><td></td><td>1450779_at</td><td>fatty acid binding protein 7, brain</td><td>Fabp7</td><td>2.16</td><td>0.000</td><td>1.52</td><td>0.21</td><td>1.66</td><td>0.05</td></tr><tr><td></td><td>1425875_a_at</td><td>leptin receptor</td><td>Lepr</td><td>2.78</td><td>0.000</td><td>&minus;1.60</td><td>0.02</td><td>&minus;1.27</td><td>0.07</td></tr><tr><td></td><td>1420715_a_at</td><td>peroxisome proliferator activated receptor gamma</td><td>Pparg</td><td>1.99</td><td>0.000</td><td>1.53</td><td>0.01</td><td>1.11</td><td>0.73</td></tr><tr><td></td><td>1417900_a_at</td><td>very low density lipoprotein receptor</td><td>Vldlr</td><td>1.81</td><td>0.001</td><td>1.01</td><td>0.86</td><td>&minus;1.08</td><td>0.40</td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt101"><p>An extensive overview is listed in <xref ref-type="supplementary-material" rid="pbio-0050002-st002">Table S2</xref>.</p></fn><fn id="nt102"><p>FC, fold change.</p></fn></table-wrap-foot> --></table-wrap>
        <p>(2) An extensive suppression of catabolic metabolism in the
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> liver, as
          evident from the significant down-regulation of key genes involved in glycolysis, the
          tricarboxylic acid cycle, and oxidative phosphorylation pathways (<xref ref-type="table" rid="pbio-0050002-t001">Table 1</xref> and <xref ref-type="supplementary-material" rid="pbio-0050002-st002">Table S2</xref>), coupled with a significant up-regulation of
          genes associated with glycogen synthesis (e.g., <italic>Gyg1</italic> and
          <italic>Gys2</italic>) and down-regulation of glycogen phosphorylase
          <italic>(Pygl),</italic> suggesting that the
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> liver stores
          glucose into glycogen, rather than burn it for energy derivation. These changes were
          further accompanied by the broad down-regulation of genes associated with electron
          transport and oxidative phosphorylation (e.g., several cytochrome P450 monooxygenases, the
          NADH dehydrogenase complex, and the NADPH-dependent oxidative metabolism) (<xref ref-type="table" rid="pbio-0050002-t001">Table 1</xref> and <xref ref-type="supplementary-material" rid="pbio-0050002-st002">Table S2</xref>) and the
          significant down-regulation of several genes associated with peroxisomal biosynthesis
            (<xref ref-type="table" rid="pbio-0050002-t001">Table 1</xref>). Apparently, the
          complete catabolic metabolism is restrained in the
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> liver.</p>
        <p>(3) A broad up-regulation of genes associated with fatty acid synthesis and transport
          (several genes listed in <xref ref-type="table" rid="pbio-0050002-t001">Table 1</xref> and
            <xref ref-type="supplementary-material" rid="pbio-0050002-st002">Table S2</xref>), the
          up-regulation of the receptor for the adipocyte hormone leptin <italic>(Lepr),</italic>
          and the central fat regulator peroxisome proliferator-activated receptor-gamma
            <italic>(Ppar</italic>γ<italic>)</italic>. Thus, similar to their reserved
          glucose utilization and enhanced glycogen synthesis,
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice attempt
          to store rather than burn fat.</p>
        <p>(4) An up-regulation of genes encoding key enzymatic and nonenzymatic
          low–molecular mass scavengers and antioxidant defense enzymes (e.g.,
            <italic>Sod1, Prdx2</italic> and <italic>3, Txnip, Ephx1, Hmox1</italic> and five
          components of the glutathione system) (<xref ref-type="table" rid="pbio-0050002-t001">Table 1</xref>), suggesting that
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice try to
          minimize the induction of (DNA) damage by counteracting ROS.</p>
        <p>None of these genes were identified as significantly differentially expressed in the
          livers of <italic>Csb<sup>m/m</sup></italic> or
            <italic>Xpa<sup>−/−</sup></italic> littermate controls (<xref ref-type="table" rid="pbio-0050002-t001">Table 1</xref>). Quantitative real-time PCR
          (Q-PCR) evaluation of the expression levels of key genes involved in the somatotroph axis,
          energy metabolism, and antioxidant defense in the livers of
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice, and
            wt<italic>, Csb<sup>m/m</sup></italic>, and
            <italic>Xpa<sup>−/−</sup></italic> littermates, as well as further
          biochemical analysis (see below), confirmed the validity of the microarray data (<xref ref-type="fig" rid="pbio-0050002-g005">Figure 5</xref>A, upper left panel).</p>
        <fig id="pbio-0050002-g005" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.0050002.g005</object-id>
          <label>Figure 5</label>
          <caption>
            <title>Expression Levels of Genes Associated with the Somatotroph Axis, Antioxidant
              Defense, and Metabolism in Mutant and wt Mouse Liver and Other Organs at Various Ages</title>
            <p><bold>(</bold>A<bold>)</bold> Q-PCR evaluation of mRNA levels of genes associated
              with antioxidant defense (dark gray bars), oxidative metabolism (light gray bars), and
              the GH/IGF1 axis (black bars) in the liver, kidney, heart, and spleen of 15-d-old
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup>,
                Csb<sup>m/m</sup>,</italic> and
              <italic>Xpa<sup>−/−</sup></italic> pups. For each gene, expression
              levels in the mutant tissue are plotted relative to that of age-matched wt control
              tissues (dotted line). Error bars indicate SEM between replicates (<italic>n</italic>
              ≥ 3).</p>
            <p>(B) Relative mRNA expression levels (fold changes, relative to embryonic day 18) of
              genes involved in the GH/IGF1 growth axis, antioxidant defense, and oxidative
              metabolism in the liver of wt and
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups,
              plotted as a function of time. Error bars indicate SEM between replicates
              (<italic>n</italic> ≥ 3).</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.g005" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s2e">
        <title>Postnatal Systemic Changes in Somatotroph Axis, Energy Metabolism, and Antioxidant
          Defense in <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> Mice</title>
        <p>Next we analyzed whether the onset of the aforementioned transcriptional changes
          paralleled the progressive postnatal growth attenuation as well as the weight loss
          observed later. Consistent with the normal embryonic development, the expression levels of
          genes involved in the somatotroph axis <italic>(Ghr, Igf1, Prlr)</italic>, antioxidant
          defense <italic>(Gstt2, Hmox1, Ephx1),</italic> and oxidative metabolism <italic>(Gck,
            Gyg1, Cs, Ndufs8)</italic> did not differ significantly between wt and
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> livers at
          postnatal day 1 (<xref ref-type="fig" rid="pbio-0050002-g005">Figure 5</xref>B). In
          contrast, during the first 2 wk of life, wt mice exhibited, as expected, a robust
          up-regulation in <italic>Igf1, Ghr,</italic> and <italic>Prlr</italic> gene expression, a
          response that was virtually absent in
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> animals
            (<xref ref-type="fig" rid="pbio-0050002-g005">Figure 5</xref>B, left panels); this
          explains well the severe growth retardation of double-mutant pups after birth. Analysis of
            <italic>Gstt2, Hmox1,</italic> and <italic>Ephx1</italic> mRNA levels revealed that the
          up-regulation of the antioxidant defense system in the
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> liver already
          initiated before postnatal day 10, and thus occurs well ahead of the initiation of the
          physiological decline (i.e., weight loss) (<xref ref-type="fig" rid="pbio-0050002-g005">Figure 5</xref>B, middle panels). When comparing mRNA levels of key genes in glycolysis
            <italic>(Gck),</italic> tricarboxylic acid cycle <italic>(Cs),</italic> and
          mitochondrial oxidative phosphorylation <italic>(Ndufs8),</italic> we noticed that
          beginning postnatal day 10,
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> livers do not
          show the prominent up-regulation of these catabolic genes seen in the wt liver (instead,
          expression levels continued to decline), whereas they up-regulate glycogen synthesis
            <italic>(Gyg1)</italic> (<xref ref-type="fig" rid="pbio-0050002-g002">Figure 2</xref>B,
          right panels). In agreement, the enzymatic activity of citrate synthase was significantly
          lower (<italic>p</italic> ≤ 0.01) in the livers of 15-d-old
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice (119
          ± 15 mU/mg protein), as compared to wt littermate controls (70 ± 13
          mU/mg protein).</p>
        <p>We next determined the expression levels of aforementioned genes in the kidney, heart,
          and spleen of the same set of animals used in the microarray experiment. Expression levels
          markedly mirrored the deviant expression patterns observed in the liver, whereas mRNA
          levels in <italic>Csb<sup>m/m</sup></italic> and
            <italic>Xpa<sup>−/−</sup></italic> tissues were not significantly
          different from wt animals (<xref ref-type="fig" rid="pbio-0050002-g005">Figure 5</xref>A).
          Thus, attenuation of the GH/IGF1 axis and down-regulation of metabolism, along with the
          enhanced antioxidant/detoxification response, represents a systemic rather than
          liver-specific response of the
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups to the DNA
          repair defect. Interestingly, when 96-wk-old wt livers were tested for expression levels
          of this same set of
          <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> responsive genes,
          we noticed a remarkable resemblance (<xref ref-type="supplementary-material" rid="pbio-0050002-sg001">Figure S1</xref>).</p>
      </sec>
      <sec id="s2f">
        <title>Comparison of the
          <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and Naturally
          Aged Mouse Liver Transcriptomes</title>
        <p>The previous result prompted us to investigate whether and to which extent the gene
          expression changes in the
          <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mouse liver
          overlap with those observed in a natural aged liver. To this end, we first compared the
          full mouse liver transcriptome of adult 16-, 96- and 130-wk-old wt C57Bl/6J mice
            (<italic>n</italic> = 4) with that of adult 8-wk-old wt C57Bl/6J mice
            (<italic>n</italic> = 4) (<xref ref-type="supplementary-material" rid="pbio-0050002-st003">Tables S3</xref>–<xref ref-type="supplementary-material" rid="pbio-0050002-st005">S5</xref>). Using the same
          analytical method as applied to the
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mouse livers,
          we identified homeostasis of energy reserves, oxidative metabolism, along with cell growth
          and maintenance to be significantly overrepresented in 96- and 130-wk-old wt mice, but not
          in 16-wk-old animals (<xref ref-type="supplementary-material" rid="pbio-0050002-st006">Table S6</xref>). These findings fit well with previous studies, suggesting the
          repression of oxidative metabolism to represent a conserved response shared by highly
          diverged species [<xref ref-type="bibr" rid="pbio-0050002-b028">28</xref>].</p>
        <p>Next we implemented a previously described method [<xref ref-type="bibr" rid="pbio-0050002-b029">29</xref>] to evaluate the extent of genome-wide
          similarity between the liver transcriptomes of 2-wk-old
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic>mice and wt
          animals of various ages. We first classified all significantly differentially expressed
          genes in the <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic>
          liver transcriptome as having increased or decreased expression (as compared to wt), and
          we asked how many of these genes respond in a similar direction in the 16/8 wk, 96/8 wk,
          and 130/8 wk datasets. If the
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> liver resembles
          an aged liver, one expects the Spearman's rank correlation coefficient
          (<italic>r</italic>, +1.0 or −1.0 in case of perfect similarity or
          dissimilarity, respectively, and 0.0 in case of no correlation) to increase with age.
          Notably, whereas the liver transcriptome of
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mutant mice
          was dissimilar to that of 16-wk-old wt mice (Spearman's <italic>r</italic> =
          −0.28), as it was with 15-d-old littermates, this turned into a positive
          correlation when the comparison was made between the
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and 96-wk-old
          mouse liver transcriptomes (<italic>r</italic> = +0.15) and even more
          with the 130-wk-old wt mouse group (<italic>r</italic> = + 0.44,
            <italic>p</italic>
          <bold>≤</bold> 0.0001) (<xref ref-type="fig" rid="pbio-0050002-g006">Figure
          6</xref>A). Comparable results were obtained when the same approach was applied over the
          whole mouse transcriptome (including all Affymetrix probe sets with signals above the
          detection cutoff value; see <xref ref-type="sec" rid="s4">Materials and Methods</xref>),
          thus avoiding any initial preselection or introduction of bias. Using the same approach,
          we did not find a significant correlation between the liver transcriptomes of 15-d-old
              <italic>Csb<sup>m/m</sup></italic> or
          <italic>Xpa<sup>−/−</sup></italic>mice and aged wt mice.</p>
        <fig id="pbio-0050002-g006" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.0050002.g006</object-id>
          <label>Figure 6</label>
          <caption>
            <title>Transcriptome Similarities between
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              Naturally Aged Mice</title>
            <p>(A) Spearman's <italic>r</italic> correlation of 16-, 96- and 130-wk-old mice with
              15-d-old <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic>
              mice, where −1.0 is a perfect negative (inverse) correlation, 0.0 is no
              correlation, and +1.0 is a perfect positive correlation.</p>
            <p>(B) Similarities between significantly overrepresented biological processes. Note
              that in both <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic>
              and naturally aged mice, transcriptional changes were mostly associated with metabolic
              processes.</p>
            <p>(C) Correlation in significant expression changes of genes associated with the
              GH/IGF1 axis and oxidative metabolism in the livers of
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
              naturally aged (96- and 130-wk-old) mice. An extensive overview is listed in <xref ref-type="supplementary-material" rid="pbio-0050002-st003">Tables S3</xref> and
                <xref ref-type="supplementary-material" rid="pbio-0050002-st004">S4</xref>.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.g006" xlink:type="simple"/>
        </fig>
        <p>The genome-wide resemblance between the short-lived
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice and the
          130-wk-old mice was substantially higher (&gt;90%) when the comparison was
          restricted to those functional categories that were significantly overrepresented in the
          double-mutant and 130-wk-old mice, such as the GH/IGF1 axis, oxidative metabolism (i.e.,
          glycolysis, Krebs and oxidative phosphorylation), cytochrome P450 electron transport, and
          peroxisomal biogenesis (<xref ref-type="fig" rid="pbio-0050002-g006">Figure 6</xref>B and
            <xref ref-type="fig" rid="pbio-0050002-g006">6</xref>C and <xref ref-type="supplementary-material" rid="pbio-0050002-st007">Table S7</xref>). Despite the
          occurrence of dissimilarities between the liver transcriptome of
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups and aged
          wt mice (the latter animals showing over-representation of genes involved in the immune
          and inflammatory responses, ATP biosynthesis, and protein glycosylation, along with a lack
          of the anti-oxidant response), these findings strongly underline the genome-wide parallels
          between the <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic>
          repair mutants and natural ageing, thereby validating the progeria in the double mutant
          pups.</p>
      </sec>
      <sec id="s2g">
        <title>Reduced IGF1 Serum Levels, Glucose, and Fat Use in
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> Mice</title>
        <p>In agreement with the down-regulation of <italic>Igf1</italic> gene expression in the
          liver (the main source of circulating IGF1 [<xref ref-type="bibr" rid="pbio-0050002-b030">30</xref>]), we observed a significant reduction
            (<italic>p</italic> &lt; 0.004) in serum IGF1 levels in
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice (<xref ref-type="fig" rid="pbio-0050002-g007">Figure 7</xref>A) together with significantly
          lower blood glucose levels (<italic>p</italic> &lt; 0.04) (<xref ref-type="fig" rid="pbio-0050002-g007">Figure 7</xref>B). Following an initial reduction of
          ∼30% (<italic>p</italic> &lt; 0.04) in 7- and 10-d-old
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice, blood
          glucose levels started to drop at day 15, gradually reaching low levels in 17-d-old
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice
          (∼3 mM), contrasting the steady blood glucose levels (∼ 9 mM) in
          littermate controls (<xref ref-type="fig" rid="pbio-0050002-g007">Figure 7</xref>B). The
          presence of milk and food in the stomach of the double-mutant pups along with the normal
          appearance of the intestinal epithelium (<xref ref-type="fig" rid="pbio-0050002-g003">Figure 3</xref>A) indicates that the hypoglycemia is not due to food intake. Even more,
          the suppression of the somatotroph axis and subsequent decreased IGF1 production in
          15-d-old <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice
          appeared not to originate from a pituitary dysfunction as histological examination (<xref ref-type="fig" rid="pbio-0050002-g003">Figure 3</xref>F) and TUNEL staining of sections
          from the pituitary pars distalis, intermedia, and nervosa did not reveal any abnormalities
          (unpublished data). Moreover, serum GH levels in 15-d-old
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice (15.2
          ± 4.2 ng/ml, <italic>n</italic> = 8) did not differ significantly
          from wt littermates (12.8 ± 2.8 ng/ml, <italic>n</italic> = 6).
          Interestingly, the normal serum GH levels together with the significant systemic down
          regulation of GH receptor gene expression likely point to growth hormone resistance in
          15-d-old <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice.</p>
        <fig id="pbio-0050002-g007" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.0050002.g007</object-id>
          <label>Figure 7</label>
          <caption>
            <title>Carbohydrate/Fat Metabolism and IGF1 Serum Levels</title>
            <p>IGF1 (A) and glucose (B) in the serum of 7-, 10-, 15-, and 17-d-old wt,
                  <italic>Xpa<sup>−/−</sup>, Csb<sup>m/m</sup>,</italic> and
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice
                (<italic>n</italic> = 6). The levels of IGF1 (ng/ml) and glucose (mmol/l)
              in the serum of
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice are
              significantly lower than that of control littermates (<italic>p</italic> &lt;
              0.0004 and <italic>p</italic> &lt; 0.04, respectively). (C) PAS staining for
              glycogen and Oil Red O staining for triglycerides in livers of 15-d-old wt and
                  <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice and
              96-wk-old wt mice. Pictures were taken at 100× magnification. Note the large
              polyploid nuclei in the 96-wk-old wt mouse liver and the reduced glycogen levels in
              the <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> liver
              after overnight fasting.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.g007" xlink:type="simple"/>
        </fig>
        <p>Periodic acid-Schiff (PAS) staining of liver sections from 10- to 20-d-old pups and
          naturally aged mice revealed enhanced accumulation of glycogen in unusually large vesicles
          in <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups and
          96-wk-old mice when compared to wt littermates and 8-wk-old wt mice (<xref ref-type="fig" rid="pbio-0050002-g007">Figure 7</xref>C)<bold>
            <italic>.</italic>
          </bold> This observation fits our microarray data, suggesting that both the
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and naturally
          aged mice store rather than use glucose. Overnight fasting of
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups and
          littermate controls resulted in a near-to-complete depletion of liver glycogen (<xref ref-type="fig" rid="pbio-0050002-g007">Figure 7</xref>D), indicating that the glycogen
          accumulation is not due to inability to split glycogen into its constitutive glucose
          monomers.</p>
        <p>Consistent with the broad up-regulation of genes associated with fatty acid synthesis
            (<xref ref-type="table" rid="pbio-0050002-t001">Table 1</xref>), Oil Red O staining of
          liver sections from 15-d-old pups and naturally aged mice revealed enhanced accumulation
          of triacylglycerides in both compared to control littermates and 8-wk-old mice (<xref ref-type="fig" rid="pbio-0050002-g007">Figure 7</xref>C), indicating hepatic steatosis.
          This and the absence of adipose tissue suggest that
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice display
          generalized lipodystrophy (loss and abnormal redistribution of body fat) [<xref ref-type="bibr" rid="pbio-0050002-b031">31</xref>].</p>
      </sec>
      <sec id="s2h">
        <title>Systemic Changes in Somatotroph Axis and Antioxidant Defense in DEHP-Treated wt Mice</title>
        <p>To test whether the presence of endogenous (oxidative) DNA damage can provoke the
          somatotrophic drop and enhanced antioxidant potential, wt C57BL/6J mice
          (<italic>n</italic> = 6; 4-wk-old) were fed ad libitum for 9 wk with standard
          food containing subtoxic levels of an oxidative DNA damage-inducing agent
          [di(2-ethylhexyl)phthalate (DEHP), 1500 ppm] [<xref ref-type="bibr" rid="pbio-0050002-b032">32</xref>]. Neither body weight nor
          appetite and food intake of DEHP-exposed animals deviated from that of untreated control
          animals. As shown in <xref ref-type="fig" rid="pbio-0050002-g008">Figure 8</xref>,
          subsequent analysis revealed suppression of the expression of genes associated with the
          somatotroph axis (<italic>Igf1, Igfbp3, Ghr,</italic> and <italic>Dio1)</italic> and
          oxidative metabolism <italic>(Gck, Cs,</italic> and <italic>Ndufs8),</italic> along with
          the up-regulation of glycogenin 1 (<italic>Gyg1,</italic>
          <xref ref-type="fig" rid="pbio-0050002-g005">Figure 5</xref>A) in DEHP-exposed animals.
          Consistent with the ability of DEHP to generate ROS-induced DNA damage in the liver, we
          also noticed a significant up-regulation of genes associated with the antioxidant and
          detoxification responses <italic>(Hmox1, Ephx1, Gsr, Sod1, Gstt2)</italic>. These findings
          suggest that the accumulation of unrepaired (oxidative) DNA damage is likely one of the
          causes underlying the observed suppression of the GH/IGF1 and oxidative metabolism in
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice (Text
          S1).</p>
        <fig id="pbio-0050002-g008" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.0050002.g008</object-id>
          <label>Figure 8</label>
          <caption>
            <title>Expression Levels of Genes Associated with the GH/IGF1 Axis, Oxidative
              Metabolism, and Antioxidant Defense in DEHP-Treated wt Mice</title>
            <p>Relative mRNA levels of genes involved in the GH/IGF1 growth axis, oxidative
              metabolism, and antioxidant defense in 13-wk-old wt mice treated with a low dose of
              the pro-oxidant DEHP. For each gene, expression levels in the treated wt mouse livers
              are plotted relative to that of age-matched untreated wt littermate controls (dotted
              line). Error bars indicate SEM. Asterisks indicate statistically significant
              differences (one-tailed <italic>p</italic> ≤ 0.05, see also Text S1).</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.g008" xlink:type="simple"/>
        </fig>
      </sec>
    </sec>
    <sec id="s3">
      <title>Discussion</title>
      <p><italic>Csb<sup>m/m</sup></italic> mice exhibit several CS features (e.g., attenuated
        growth, blindness, neurological dysfunction), but their phenotype is overall milder than the
        human syndrome [<xref ref-type="bibr" rid="pbio-0050002-b016">16</xref>]
        despite the fact that the truncation in the N-terminal part (mimicking a mutant allele of
        CS-B patient CS1AN) completely inactivates the protein and TC-NER [<xref ref-type="bibr" rid="pbio-0050002-b016">16</xref>]. Although the severity of
        clinical features in humans does not seem to correlate with the severity of the molecular
        defect [<xref ref-type="bibr" rid="pbio-0050002-b033">33</xref>], the
        absence of the complete spectrum of CS features in the <italic>Csb<sup>m/m</sup></italic>
        mouse model is likely to originate from human-mouse differences (i.e., adaptation to stress,
        tolerance to DNA damage/genome instability), rather than from the nature of the
            <italic>Csb<sup>m/m</sup></italic> mutation. This idea is supported by our observations
        that <italic>Xpd<sup>TTD</sup></italic> and <italic>Xpd<sup>XPCS</sup></italic> mice (all
        carrying causative point mutations) also fail to show the severe CS features associated with
        XPCS and TTD [<xref ref-type="bibr" rid="pbio-0050002-b009">9</xref>,<xref ref-type="bibr" rid="pbio-0050002-b034">34</xref>].</p>
      <p>Yet, the present study reveals that inactivation of GG-NER or complete abrogation of NER
        (through inactivation of <italic>Xpc</italic> or <italic>Xpa,</italic> respectively) in
        TCR-deficient <italic>Csb<sup>m/m</sup></italic> mice dramatically aggravates the
            <italic>Csb<sup>m/m</sup></italic> mouse phenotype. Because animals were not exposed to
        exogenous genotoxic agents, we attribute this effect to enhanced levels of unrepaired
        endogenous (oxidative) DNA damage. In further support of this, we have shown that
            <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> and
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> MEFs, as well
        as <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> retinal
        photoreceptor cells, are more sensitive to environmental genotoxic insults (i.e., UV light
        and ionizing radiation) than their single mutant counterparts. A comparable phenotypic
        deterioration has been noticed when <italic>Xpa</italic> was inactivated in
            <italic>Xpd<sup>TTD</sup></italic> [<xref ref-type="bibr" rid="pbio-0050002-b009">9</xref>], <italic>Xpd<sup>XPCS</sup></italic>
          [<xref ref-type="bibr" rid="pbio-0050002-b034">34</xref>], compound
        heterozygous <italic>Xpd<sup>TTD/XPCS</sup></italic> animals (carrying causative mutations
        for TTD and combined XP/CS) [<xref ref-type="bibr" rid="pbio-0050002-b035">35</xref>] or <italic>Xpg<sup>deltaEx15</sup></italic> mice [<xref ref-type="bibr" rid="pbio-0050002-b036">36</xref>].</p>
      <p>Importantly, <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice
        appeared normal at birth, indicating a normal intra-uterine development and ruling out that
        this condition is in fact an embryonic developmental disorder. Instead, after birth, the
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups displayed
        progressive kyphosis, cachexia, photoreceptor loss, and motor dysfunction, all common
        postnatal manifestations of CS [<xref ref-type="bibr" rid="pbio-0050002-b013">13</xref>], as well as of natural mammalian ageing [<xref ref-type="bibr" rid="pbio-0050002-b037">37</xref>–<xref ref-type="bibr" rid="pbio-0050002-b039">39</xref>]. Also similar to human CS patients (average age 12.5 y),
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups fail to
        grow into adulthood and die before weaning. The relation between (residual) repair capacity,
        time, and severity of a particular phenotype is well illustrated by the retinal
        photoreceptor loss in the <italic>Csb<sup>m/m</sup></italic> mouse models. Whereas ageing
        C57Bl/6J mice lose about 5%–10% of their rods and cones in
        30 months, TCR-deficient <italic>Csb<sup>m/m</sup></italic> mice have already lost about
        50% of their photoreceptor cells by the age of 16 months. This spontaneous
        retinal degeneration in <italic>Csb<sup>m/m</sup></italic> mice originates from enhanced
        apoptotic sensitivity of photoreceptor cells (T. Gorgels, I. van der Pluijm, R. Brandt, G.
        Garinis, H. van Steeg, et al, unpublished data), evolving in the first 1 or 2 months after
        weaning. Interestingly, further crippling of NER in <italic>Csb<sup>m/m</sup></italic>
        animals by inactivation of <italic>Xpa</italic> accelerates the onset of photoreceptor loss,
        which becomes visible as early as postnatal day 15, and progressively increases thereafter.
        The strong correlation between the severity of the repair deficiency and the onset of
        photoreceptor loss, as well as the enhanced ionizing radiation hypersensitivity of
        photoreceptor cells of
        <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice (as compared
        to age-matched <italic>Csb<sup>m/m</sup></italic> animals), well support the hypothesis that
        (oxidative) DNA damage likely underlies the retinal degeneration.</p>
      <p>Full genome transcriptome analysis of the
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mouse liver,
        aiming at unraveling the etiology of the severe double-mutant phenotype, led us to identify
        significant genome-wide parallels between the 2-wk-old
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and 130-wk, but
        not 16-wk-old, wt animals at the fundamental level of gene expression. This resemblance was
        largely attributable to the substantial down-regulation of genes associated with processes
        implicated in oxidative energy and growth metabolism that were previously revealed by others
        to represent a conserved transcriptional response in ageing [<xref ref-type="bibr" rid="pbio-0050002-b028">28</xref>].</p>
      <p>The down-regulation of genes associated with the GH/IGF1 growth axis in the liver, the
        systemic reduction in <italic>GH receptor</italic> mRNA levels, and the impaired
          <italic>Igf1</italic> gene expression in liver and other tissues (resulting in low serum
        IGF1 levels) likely underlie the postnatal growth defect in
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups. These
        changes were not due to reduced GH serum levels or pituitary abnormalities. A steady decline
        in the GH/IGF1 somatotroph axis was also observed in rodents and humans during natural
        ageing [<xref ref-type="bibr" rid="pbio-0050002-b040">40</xref>].
          Furthermore<italic>, Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups
        failed to up-regulate metabolism; instead, they displayed a sharp systemic reduction in the
        expression levels of genes involved in glycolysis, tricarboxylic acid cycle (including
        decreased citrate synthase activity), and oxidative respiration, which coincided with the
        onset of weight loss (cachexia). In addition,
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> pups
        up-regulated genes associated with glycogen and fatty acid synthesis, leading to increased
        hepatic glycogen storage and fat accumulation (steatosis) and pronounced hypoglycemia.
        Simultaneously, subcutaneous fat tissue was virtually absent. Given that in mammals, the
        GH/IGF1 signaling pathway is one of the major regulators of energy homeostasis to integrate
        metabolism with growth [<xref ref-type="bibr" rid="pbio-0050002-b030">30</xref>,<xref ref-type="bibr" rid="pbio-0050002-b041">41</xref>,<xref ref-type="bibr" rid="pbio-0050002-b042">42</xref>], it is tempting to speculate that reduced IGF1
        signaling is responsible for the postnatal metabolic shift and growth defect seen in
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice.
        Interestingly, several CS patients have been previously reported with hypoglycemia and low
        IGF1 serum levels [<xref ref-type="bibr" rid="pbio-0050002-b043">43</xref>,<xref ref-type="bibr" rid="pbio-0050002-b044">44</xref>], low metabolic rate
          [<xref ref-type="bibr" rid="pbio-0050002-b045">45</xref>], and abnormal
        fat deposition [<xref ref-type="bibr" rid="pbio-0050002-b046">46</xref>].</p>
      <p>Paradoxically, however, the systemic suppression of the somatotrophic axis and energy
        metabolism, along with the up-regulation of antioxidant defenses, low IGF1 serum levels, and
        low blood glucose levels observed in the
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mouse, are all
        associated with increased longevity rather than with the short lifespan of this mouse model.
        In lower paradigms for lifespan extension <italic>(C. elegans, D. melanogaster),</italic>
        genetic interference in the insulin-signaling pathway can prolong life multi-fold
          [<xref ref-type="bibr" rid="pbio-0050002-b047">47</xref>,<xref ref-type="bibr" rid="pbio-0050002-b048">48</xref>]. In mammals, IGF1-deficient, Ames and Snell
        dwarf mice (characterized by defects in the development of the anterior pituitary due to
        mutations in the <italic>Prop-1</italic> and <italic>Pit1</italic> loci and diminished
        levels of GH, thyroid stimulating hormone, and prolactin hormone) combine hypoglycemia, low
        body temperature, and increased storage of carbohydrates and lipids [<xref ref-type="bibr" rid="pbio-0050002-b040">40</xref>,<xref ref-type="bibr" rid="pbio-0050002-b042">42</xref>] with up-regulation of antioxidant defense
        capacity and extended lifespan [<xref ref-type="bibr" rid="pbio-0050002-b049">49</xref>,<xref ref-type="bibr" rid="pbio-0050002-b050">50</xref>]. Conversely,
        GH-overexpressing transgenic mice display reduced lifespan and antioxidant responses
          [<xref ref-type="bibr" rid="pbio-0050002-b051">51</xref>]. These
        findings have also been recently confirmed by our identification of genome-wide parallels
        between the extremely short-lived DNA repair mutants
            (<italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
            <italic>Ercc1<sup>−/−</sup></italic>) and the extremely long-lived
        Ames and Snell dwarfs and growth hormone receptor knockout
            <italic>(Ghr<sup>−/−</sup>)</italic> mice (Garinis <italic>et
        al</italic>. manuscript in preparation). Last but not least, IGF1 plasma levels decline with
        age in humans and rodents [<xref ref-type="bibr" rid="pbio-0050002-b052">52</xref>–<xref ref-type="bibr" rid="pbio-0050002-b054">54</xref>].
        Along with this hormonal shift, ageing cells surmount an intricate antioxidant defense
        response [<xref ref-type="bibr" rid="pbio-0050002-b055">55</xref>,<xref ref-type="bibr" rid="pbio-0050002-b056">56</xref>] that is thought to prevent the
        detrimental consequences of oxidative stress. Interestingly, the progressive, age-related
        decrease in the somatotroph axis has been suggested to confer a selective advantage by
        postponing the onset of age-related disease and prolonging lifespan through the reduction of
        toxic free radicals [<xref ref-type="bibr" rid="pbio-0050002-b040">40</xref>].</p>
      <p>How would repair-deficient mice benefit from such a response? During development, the
        mitogenic action of GH and IGF1 fuels cellular metabolism, thereby promoting tissue growth
        and function [<xref ref-type="bibr" rid="pbio-0050002-b040">40</xref>,<xref ref-type="bibr" rid="pbio-0050002-b057">57</xref>,<xref ref-type="bibr" rid="pbio-0050002-b058">58</xref>]. A high metabolic activity, however, leads to
        higher oxygen consumption [<xref ref-type="bibr" rid="pbio-0050002-b040">40</xref>] and may also increase the ROS burden through the parallel increase of
        mitochondrial electron transport, peroxisomal fatty acid metabolism, and/or microsomal
        cytochrome <italic>P-450</italic> enzymes [<xref ref-type="bibr" rid="pbio-0050002-b059">59</xref>]. Despite antioxidant defense and DNA repair,
        oxidative DNA damage will still accumulate, leading to transcriptional stress, impaired
        replication, cellular senescence, malfunction or death and eventually to progressive loss of
        tissue homeostasis and organismal decline (<xref ref-type="fig" rid="pbio-0050002-g009">Figure 9</xref>, model). We hypothesize that complete abrogation of NER (by inactivation
        of <italic>Xpa</italic>) renders TCR-deficient <italic>Csb<sup>m/m</sup></italic> mice
        unable to adequately cope with the increased burden of DNA damage in the transcribed strand
        of active genes. This triggers an adaptive response; i.e., reduction of metabolic activity
        through down-regulation of the GH/IGF1 axis to relieve the pressure on their genome. We
        interpret this as an attempt to limit the deleterious effects of arrested transcription,
        such as cellular senescence and death causing accelerated ageing. As a consequence, the
        initially normal growth becomes arrested soon after birth, leading to severe growth
        retardation. This scenario provides a plausible explanation for the growth defect in CS
        patients. However, this response is unable to fully compensate for the repair defect, and
        thus damage still accumulates to critical levels and triggers apoptosis and/or senescence,
        thereby leading to ageing-associated pathology such as neurodegeneration (as illustrated by
        the photoreceptor cells in
        <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice).</p>
      <fig id="pbio-0050002-g009" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pbio.0050002.g009</object-id>
        <label>Figure 9</label>
        <caption>
          <title>The Proposed Link between DNA Damage and the Decline of the GH/IGF1 Somatotroph
            Axis</title>
          <p>ROS are natural byproducts of metabolism and can injure several macromolecules
            including DNA, thus contributing to a slow but steady accumulation of damage,
            transcriptional stress, impaired replication, and eventually the progressive loss of
            tissue homeostasis and gradual organismal deterioration. Cells and tissues will respond
            by (1) up-regulating their antioxidant defense responses that would moderate the harmful
            effects of ROS, (2) using a battery of genome maintenance pathways that would repair or
            remove damaged macromolecules and help to resist the oxidative stress, and (3)
            suppressing their GH/IGF1 somatotroph axis along with the oxidative metabolism, thus
            substantially moderating their metabolic activity that would otherwise lead to high
            oxygen consumption and increased generation of oxidants. To this end, the physiologic
            reduction of the somatotroph axis and oxidative metabolism is envisaged to be beneficial
            in terms of net lifespan.</p>
        </caption>
        <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.g009" xlink:type="simple"/>
      </fig>
      <p>The conceptual link between DNA damage and the systemic adaptive response is supported by
        our observation that chronic exposure of wt mice to a sub-toxic dose of DEHP (a pro-oxidant
        that enhances the DNA damage load; [<xref ref-type="bibr" rid="pbio-0050002-b060">60</xref>]) triggers a response similar to that observed in (untreated)
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice. Although
        DEHP at much higher concentrations has been previously documented to affect the endocrine
        function of the pituitary, proteome analysis revealed that synthesis of prolactin and growth
        hormone appears unaffected in DEHP-treated rats [<xref ref-type="bibr" rid="pbio-0050002-b061">61</xref>]. This suggests that the observed suppression
        of genes associated with the somatotroph axis and oxidative metabolism in the liver of
        DEHP-exposed mice is triggered by DNA damage in the liver, rather than by a pituitary defect
        or hypothalamic defect.</p>
      <p>As one would predict, other short-lived NER mouse models (e.g., <italic>Xpg</italic> and
          <italic>Xpf</italic> mice [<xref ref-type="bibr" rid="pbio-0050002-b062">62</xref>,<xref ref-type="bibr" rid="pbio-0050002-b063">63</xref>]) or NER
        mutant mice with a milder progeroid phenotype could also show accelerated attenuation of the
        somatotrophic axis in response to their DNA repair defect. Indeed,
            <italic>Ercc1<sup>−/−</sup></italic> animals, carrying a combined
        NER/crosslink DNA repair defect and a lifespan of only a few weeks, demonstrate a remarkable
        genome-wide similarity in liver gene expression profiles with
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice (L.
        Niedernhofer, G. Garinis, A. Raams, A. Lalai, A. Rasile Robinson, et al., unpublished data),
        whereas <italic>Xpd<sup>XPCS</sup>/Xpa<sup>−/−</sup></italic> and
        compound heterozygous
        <italic>Xpd<sup>TTD/XPCS</sup>/Xpa<sup>−/−</sup></italic> mice contain
        lower serum IGF1 levels [<xref ref-type="bibr" rid="pbio-0050002-b035">35</xref>]. Furthermore, <italic>Xpd<sup>TTD</sup></italic> mice, which manifest
        accelerated ageing in many (but not all) organs and tissues, have recently been shown to
        display features related to a caloric restricted–like phenotype and suppression of
        the GH/IGF1 axis in a limited set of organs and tissues, stressing the segmental nature that
        is characteristic of all progeroid syndromes and the systemic nature of the response
          [<xref ref-type="bibr" rid="pbio-0050002-b064">64</xref>]. Finally,
        proper glucose homeostasis and normal IGF1 levels were recently shown to require activity of
        Sirt6, a chromatin deacetylase that may promote DNA repair [<xref ref-type="bibr" rid="pbio-0050002-b065">65</xref>]. Because ROS-mediated DNA damage appears to be
        the underlying cause of the
        <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> progeria, it is
        tempting to speculate that one can attenuate the premature onset of age-related features by
        directly counteracting the harmful byproducts of metabolism (ROS) and, consequently, DNA
        damage. An antioxidant-based nutraceutical intervention pilot study with
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice, aiming at
        extending lifespan and delaying onset of pathology, yielded promising results (I. van der
        Pluijm, R. Brandt, J. Hoeijmakers, G. van der Horst, unpublished data).</p>
    </sec>
    <sec id="s4">
      <title>Materials and Methods</title>
      <sec id="s4a">
        <title>Animals.</title>
        <p>The generation and characterization of NER-deficient
              <italic>Xpa<sup>−/−</sup>,
          Xpc<sup>−/−</sup>,</italic> and <italic>Csb<sup>m/m</sup></italic>
          mice has been previously described [<xref ref-type="bibr" rid="pbio-0050002-b016">16</xref>,<xref ref-type="bibr" rid="pbio-0050002-b022">22</xref>,<xref ref-type="bibr" rid="pbio-0050002-b066">66</xref>,<xref ref-type="bibr" rid="pbio-0050002-b067">67</xref>]. <italic>p53<sup> −/−</sup></italic>
          mice [<xref ref-type="bibr" rid="pbio-0050002-b068">68</xref>] were
          kindly provided by T. Jacks (Massachusetts Institute of Technology, Cambridge,
          Massachusetts, United States). Unless stated otherwise, all mice were kept in a C57BL/6J
          genetic background. In the DEHP exposure study, 4-wk-old male wt mice (C57BL/6J;
          <italic>n</italic> = 6) were put on a DEHP (1500 ppm; Sigma, St. Louis,
          Missouri, United States) containing diet or on a regular diet for 9 wk. Animals were
          screened daily for discomfort and weighed once a week. Food consumption was registered by
          weighing the food. In the ionizing irradiation exposure study, 18-d-old
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
          littermate control animals (<italic>n</italic> = 4–6/genotype) were
          exposed to 10 Gy, killed 20 h after exposure, and their eyes were further processed.
          Additional information on the isolation and processing of the eyes is provided in the Text
          S1. As required by Dutch law, all animal studies were approved by an independent Animal
          Ethical Committee (Dutch equivalent of the Institutional Animal Care and Use Committee).
          Further information on mouse crossing, genotyping, housing, and macroscopic examination is
          described in the Text S1.</p>
      </sec>
      <sec id="s4b">
        <title>Cellular sensitivity studies.</title>
        <p>UV sensitivity was determined as described [<xref ref-type="bibr" rid="pbio-0050002-b069">69</xref>]. Sparsely seeded Petri dish cultures were
          exposed to different doses of UV (254 nm, Phillips TUV lamp). After 4 d, the number of
          proliferating cells was estimated from the amount of radioactivity incorporated during a
          2-hr pulse with [<sup>3</sup>H] thymidine. Cell survival was expressed
          as the percentage of radioactivity in exposed cells in relation to the radioactivity in
          untreated cells. UV-induced GG repair was assayed using the unscheduled DNA synthesis
          (UDS) method described in [<xref ref-type="bibr" rid="pbio-0050002-b070">70</xref>]. In brief, coverslip-grown cells were exposed to 16 J/m<sup>2</sup>
          of 254-nm UV light and labeled with [<sup>3</sup>H] thymidine. Repair
          capacity was quantified by grain counting after autoradiography. RNA synthesis recovery
          was measured according to [<xref ref-type="bibr" rid="pbio-0050002-b071">71</xref>]. In short, coverslip-grown cells were exposed to 10 J/m<sup>2</sup>
          of 254-nm UV light, allowed to recover for 16 hr, labeled with
          [<sup>3</sup>H] uridine, and processed for autoradiography. The relative
          rate of RNA synthesis was expressed as
            <italic>G</italic><sub>UV</sub>/<italic>G</italic><sub>C</sub> (percentage), where
            <italic>G</italic><sub>UV</sub> and <italic>G</italic><sub>C</sub> represent the number
          of grains over UV-exposed and nonexposed nuclei, respectively.</p>
        <p>Ionizing radiation sensitivity of immortalized MEFs was determined using a colony assay.
          Cells were plated in 6-cm-diameter dishes at various densities. After 16 h, cells were
          exposed to a single dose of ionizing radiation (<sup>137</sup>Cs source; dose range of 0
          to 8 Gy. Cells were grown for another 5 to 14 d, and after fixation and staining, colonies
          were counted. All experiments were performed in triplicate.</p>
      </sec>
      <sec id="s4c">
        <title>Immunohistological examination and blood parameters.</title>
        <p>Detailed histopathological examination was performed on all organs and tissues.
          Paraffin-embedded tissues were sectioned at 5 μm and stained with
          haematoxylin/eosin (HE) solution. Liver sections were stained with PAS or Oil Red O
          (cryosections) to detect glycogen and triglycerides, respectively. Detailed information on
          the immunohistochemical procedures is described in Text S1. Apoptotic cells were detected
          using a TUNEL assay as described by the manufacturer (Apoptag Plus Peroxidase In Situ
          Apoptosis Detection Kit, Chemicon, Temecula, California, United States). For retinal
          evaluation, eyes were marked nasally with Alcian blue (5% Alcian blue in
          96% ethanol), enucleated, fixed in 4 % paraformaldehyde in 0.1 M
          phosphate buffer, washed in PBS, and embedded in paraffin. Horizontal sections (5
          μm thick) of the retina were cut, and sections in the middle of the retina were
          selected by Alcian blue marking and proximity of the optic nerve. Sections were stained
          for degenerating cells by TUNEL according to the manufacturer's instructions (Apoptag Plus
          Peroxidase In Situ Apoptosis Detection Kit, Chemicon). For quantification, the number of
          TUNEL-positive cells in the INL and ONL were counted in six whole sections per mouse.
          Differences between the genotypes were tested for statistical significance using
          multivariate ANOVA, followed by a posthoc test of Student-Newman-Keuls (S-N-K).
          Significance was set at <italic>p</italic> &lt; 0.05. Serum IGF1 and GH levels were
          determined with the active mouse/rat IGF1 enzyme-linked immunosorbent assay (ELISA) and
          active mouse/rat GH ELISA kits respectively, as described by the manufacturer (Diagnostic
          Systems Laboratories Inc., Texas, United States). Blood glucose was measured using a
          Freestyle mini blood glucose measurement device (Abbott Diabetes Care, Amersfoort, The
          Netherlands).</p>
      </sec>
      <sec id="s4d">
        <title>Radiography and microcomputed tomography.</title>
        <p>Mice were anaesthetized by intraperitoneal injection of ketalin and rompun (120 and 7.5
          μg/g body weight, respectively). Lateral films were taken at 2×
          magnification using a CGR Senograph 500T x-ray system operated at 30 kV and 32 mAS
            [<xref ref-type="bibr" rid="pbio-0050002-b009">9</xref>]. Formalin
          fixed tibiae from wt and mutant mice were scanned from proximal end to mid-diaphysis,
          using a SkyScan 1072 microtomograph (SkyScan, Antwerp, Belgium) with a voxel size of 8.82
          μm. Scans were processed, and 2-D images of the bones were obtained.</p>
      </sec>
      <sec id="s4e">
        <title>Footprint studies.</title>
        <p>Footprint analysis was performed by painting the hind and fore paws of the mice with
          different colors of water-soluble nontoxic paints. Animals were allowed to walk along a 30
          × 7 cm walled runway, lined with paper, into a darkened, enclosed space. Tests
          were performed in duplicate at day 15 and 19. Footprint patterns were analyzed for (1)
          stride length, measured as the average distance between each stride; (2) front base width;
          and (3) hind base width, measured as the average distance between contralateral footprints
            [<xref ref-type="bibr" rid="pbio-0050002-b072">72</xref>].</p>
      </sec>
      <sec id="s4f">
        <title>Microarray analysis and Q-PCR evaluation.</title>
        <p>Standard procedures were used to obtain total RNA (Qiagen, Valencia, California, United
          States) from the liver of wt, <italic>Xpa<sup>−/−</sup>,
            Csb<sup>m/m</sup>,</italic> and
              <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice
            (<italic>n</italic> = 4) at postnatal day 15 and from the liver of 8-, 16-,
          96-, and 130-wk-old mice (<italic>n</italic> = 4). Synthesis of double stranded
          cDNA and biotin-labeled cRNA was performed according to the instructions of the
          manufacturer (Affymetrix, Santa Clara, California, United States). Fragmented cRNA
          preparations were hybridized to full mouse genome oligonucleotide arrays (430 V2.0;
          Affymetrix). Q-PCR was performed with a DNA Engine Opticon device (Bio-Rad Laboratories
          B.V., Veenendaal, The Netherlands). Detailed information on microarray hybridization,
          microarray data analysis, gene ontology classification, and analysis of overrepresented
          biological themes, as well as on Q-PCR data analysis and used primer pair sequences is
          described in Text S1. Microarrays were complied with the Minimum Information for
          Microarray Experiments (MIAME, E-MEXP-835 and E-MEXP-839).</p>
      </sec>
    </sec>
    <sec id="s5">
      <title>Supporting Information</title>
      <supplementary-material id="pbio-0050002-sg001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.sg001" xlink:type="simple">
        <label>Figure S1</label>
        <caption>
          <title>Q-PCR Evaluation of mRNA Levels of Genes Associated with the GH/IGF1 Axis,
            Antioxidant Defense, and Oxidative Metabolism in 2-wk-Old
                <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
            96-wk-Old wt Mice</title>
          <p>(114 KB TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio-0050002-st001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.st001" xlink:type="simple">
        <label>Table S1</label>
        <caption>
          <title>Frequency of Viable
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> and
                <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> Mice and
            Parallels of Human and Mouse CS Symptoms</title>
          <p>(A) Frequency of viable
            <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mice; (B)
            frequency of viable
            <italic>Csb<sup>m/m</sup>/Xpc<sup>−/−</sup></italic> mice; (C)
            parallels of human CS symptoms with the mild <italic>Csb<sup>m/m</sup></italic> and
            severe <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup></italic> mouse
            models.</p>
          <p>(13 KB PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio-0050002-st002" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.st002" xlink:type="simple">
        <label>Table S2</label>
        <caption>
          <title>Extensive Overview of Significant Expression Changes in
                <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup>,
            Csb<sup>m/m</sup>,</italic> and <italic>Xpa<sup>−/−</sup></italic>
            Mice Compared to wt Littermate Controls</title>
          <p>(129 KB PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio-0050002-st003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.st003" xlink:type="simple">
        <label>Table S3</label>
        <caption>
          <title>Extensive Overview of Significant Expression Changes in 130-wk-Old wt Mice Compared
            to 8-wk-Old Mice</title>
          <p>(92 KB PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio-0050002-st004" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.st004" xlink:type="simple">
        <label>Table S4</label>
        <caption>
          <title>Extensive Overview of Significant Expression Changes in 96-wk-Old wt Mice Compared
            to 8-wk-Old Mice</title>
          <p>(121 KB PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio-0050002-st005" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.st005" xlink:type="simple">
        <label>Table S5</label>
        <caption>
          <title>Extensive Overview of Significant Expression Changes in 16-wk-Old wt Mice Compared
            to 8-wk-Old Mice</title>
          <p>(106 KB PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio-0050002-st006" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.st006" xlink:type="simple">
        <label>Table S6</label>
        <caption>
          <title>Extensive Overview of Gene Expression Profiles Associated with Significantly
            Over-represented Biological Processes in 96- and 130-wk-Old Naturally Aged Mice</title>
          <p>(13 KB PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio-0050002-st007" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.st007" xlink:type="simple">
        <label>Table S7</label>
        <caption>
          <title>Comparison of Gene Expression Profiles Associated with Significantly
            Over-represented Biological Processes between
                <italic>Csb<sup>m/m</sup>/Xpa<sup>−/−</sup>,
            Csb<sup>m/m</sup>,</italic> and <italic>Xpa<sup>−/−</sup></italic>
            Mice and 96- and 130-wk-Old Naturally Aged Mice</title>
          <p>(11 KB PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio-0050002-sd001" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pbio.0050002.sd001" xlink:type="simple">
        <label>Text S1</label>
        <caption>
          <title>Supplementary Methods</title>
          <p>(42 KB DOC)</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank Wiebeke van Leeuwen and Willem Sluiter for assistance with x-ray analysis and
        citrate synthase activity measurements, respectively.</p>
    </ack>
    
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ANOVA</term>
          <def>
            <p>analysis of variance</p>
          </def>
        </def-item>
        <def-item>
          <term>BrdU</term>
          <def>
            <p>bromodeoxyuridine</p>
          </def>
        </def-item>
        <def-item>
          <term>CS</term>
          <def>
            <p>Cockayne syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term>DEHP</term>
          <def>
            <p>di(2-ethylhexyl)phthalate</p>
          </def>
        </def-item>
        <def-item>
          <term>GG-NER</term>
          <def>
            <p>global genome–nucleotide excision repair</p>
          </def>
        </def-item>
        <def-item>
          <term>GH</term>
          <def>
            <p>growth hormone</p>
          </def>
        </def-item>
        <def-item>
          <term>IGF1</term>
          <def>
            <p>insulin-like growth factor 1</p>
          </def>
        </def-item>
        <def-item>
          <term>INL</term>
          <def>
            <p>inner nuclear layer</p>
          </def>
        </def-item>
        <def-item>
          <term>IR</term>
          <def>
            <p>ionizing radiation</p>
          </def>
        </def-item>
        <def-item>
          <term>MEF</term>
          <def>
            <p>mouse embryonic fibroblast</p>
          </def>
        </def-item>
        <def-item>
          <term>NER</term>
          <def>
            <p>nucleotide excision repair</p>
          </def>
        </def-item>
        <def-item>
          <term>ONL</term>
          <def>
            <p>outer nuclear layer</p>
          </def>
        </def-item>
        <def-item>
          <term>PAS</term>
          <def>
            <p>periodic acid-Schiff</p>
          </def>
        </def-item>
        <def-item>
          <term>ROS</term>
          <def>
            <p>reactive oxygen species</p>
          </def>
        </def-item>
        <def-item>
          <term>SEM</term>
          <def>
            <p>standard error of the mean</p>
          </def>
        </def-item>
        <def-item>
          <term>TC-NER</term>
          <def>
            <p>transcription-coupled nucleotide excision repair</p>
          </def>
        </def-item>
        <def-item>
          <term>TCR</term>
          <def>
            <p>transcription-coupled repair</p>
          </def>
        </def-item>
        <def-item>
          <term>TTD</term>
          <def>
            <p>trichothiodystrophy</p>
          </def>
        </def-item>
        <def-item>
          <term>TUNEL</term>
          <def>
            <p>terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling</p>
          </def>
        </def-item>
        <def-item>
          <term>XP</term>
          <def>
            <p>xeroderma pigmentosum</p>
          </def>
        </def-item>
        <def-item>
          <term>wt</term>
          <def>
            <p>wild-type</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <title>References</title>
      <ref id="pbio-0050002-b001">
        <label>1</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Harman</surname><given-names>D</given-names></name></person-group>
          <year>1956</year>
          <article-title>Aging: A theory based on free radical and radiation chemistry.</article-title>
          <source>J Gerontol</source>
          <volume>11</volume>
          <fpage>298</fpage>
          <lpage>300</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b002">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Schriner</surname><given-names>SE</given-names></name><name name-style="western"><surname>Linford</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Martin</surname><given-names>GM</given-names></name><name name-style="western"><surname>Treuting</surname><given-names>P</given-names></name><name name-style="western"><surname>Ogburn</surname><given-names>CE</given-names></name><etal/></person-group>
          <year>2005</year>
          <article-title>Extension of murine life span by overexpression of catalase targeted to
            mitochondria.</article-title>
          <source>Science</source>
          <volume>308</volume>
          <fpage>1909</fpage>
          <lpage>1911</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b003">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Melov</surname><given-names>S</given-names></name><name name-style="western"><surname>Ravenscroft</surname><given-names>J</given-names></name><name name-style="western"><surname>Malik</surname><given-names>S</given-names></name><name name-style="western"><surname>Gill</surname><given-names>MS</given-names></name><name name-style="western"><surname>Walker</surname><given-names>DW</given-names></name><etal/></person-group>
          <year>2000</year>
          <article-title>Extension of life-span with superoxide dismutase/catalase mimetics.</article-title>
          <source>Science</source>
          <volume>289</volume>
          <fpage>1567</fpage>
          <lpage>1569</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b004">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Orr</surname><given-names>WC</given-names></name><name name-style="western"><surname>Sohal</surname><given-names>RS</given-names></name></person-group>
          <year>1994</year>
          <article-title>Extension of life-span by overexpression of superoxide dismutase and
            catalase in <italic>Drosophila melanogaster</italic>.</article-title>
          <source>Science</source>
          <volume>263</volume>
          <fpage>1128</fpage>
          <lpage>1130</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b005">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Ishii</surname><given-names>N</given-names></name><name name-style="western"><surname>Fujii</surname><given-names>M</given-names></name><name name-style="western"><surname>Hartman</surname><given-names>PS</given-names></name><name name-style="western"><surname>Tsuda</surname><given-names>M</given-names></name><name name-style="western"><surname>Yasuda</surname><given-names>K</given-names></name><etal/></person-group>
          <year>1998</year>
          <article-title>A mutation in succinate dehydrogenase cytochrome b causes oxidative stress
            and ageing in nematodes.</article-title>
          <source>Nature</source>
          <volume>394</volume>
          <fpage>694</fpage>
          <lpage>697</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b006">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Hamilton</surname><given-names>ML</given-names></name><name name-style="western"><surname>Van Remmen</surname><given-names>H</given-names></name><name name-style="western"><surname>Drake</surname><given-names>JA</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Guo</surname><given-names>ZM</given-names></name><etal/></person-group>
          <year>2001</year>
          <article-title>Does oxidative damage to DNA increase with age?</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <volume>98</volume>
          <fpage>10469</fpage>
          <lpage>10474</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b007">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>T</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kao</surname><given-names>SY</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Kohane</surname><given-names>I</given-names></name><etal/></person-group>
          <year>2004</year>
          <article-title>Gene regulation and DNA damage in the ageing human brain.</article-title>
          <source>Nature</source>
          <volume>429</volume>
          <fpage>883</fpage>
          <lpage>891</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b008">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>GM</given-names></name></person-group>
          <year>2005</year>
          <article-title>Genetic modulation of senescent phenotypes in <named-content content-type="genus-species" xlink:type="simple">Homo sapiens</named-content>.</article-title>
          <source>Cell</source>
          <volume>120</volume>
          <fpage>523</fpage>
          <lpage>532</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b009">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>de Boer</surname><given-names>J</given-names></name><name name-style="western"><surname>Andressoo</surname><given-names>JO</given-names></name><name name-style="western"><surname>de Wit</surname><given-names>J</given-names></name><name name-style="western"><surname>Huijmans</surname><given-names>J</given-names></name><name name-style="western"><surname>Beems</surname><given-names>RB</given-names></name><etal/></person-group>
          <year>2002</year>
          <article-title>Premature aging in mice deficient in DNA repair and transcription.</article-title>
          <source>Science</source>
          <volume>296</volume>
          <fpage>1276</fpage>
          <lpage>1279</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b010">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Hanawalt</surname><given-names>PC</given-names></name></person-group>
          <year>2002</year>
          <article-title>Subpathways of nucleotide excision repair and their regulation.</article-title>
          <source>Oncogene</source>
          <volume>21</volume>
          <fpage>8949</fpage>
          <lpage>8956</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b011">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Spivak</surname><given-names>G</given-names></name><name name-style="western"><surname>Hanawalt</surname><given-names>PC</given-names></name></person-group>
          <year>2006</year>
          <article-title>Host cell reactivation of plasmids containing oxidative DNA lesions is
            defective in Cockayne syndrome but normal in UV-sensitive syndrome fibroblasts.</article-title>
          <source>DNA Repair (Amst)</source>
          <volume>5</volume>
          <fpage>13</fpage>
          <lpage>22</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b012">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>de Waard</surname><given-names>H</given-names></name><name name-style="western"><surname>de Wit</surname><given-names>J</given-names></name><name name-style="western"><surname>Gorgels</surname><given-names>TG</given-names></name><name name-style="western"><surname>van den Aardweg</surname><given-names>G</given-names></name><name name-style="western"><surname>Andressoo</surname><given-names>JO</given-names></name><etal/></person-group>
          <year>2003</year>
          <article-title>Cell type-specific hypersensitivity to oxidative damage in CSB and XPA
            mice.</article-title>
          <source>DNA Repair (Amst)</source>
          <volume>2</volume>
          <fpage>13</fpage>
          <lpage>25</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b013">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Nance</surname><given-names>MA</given-names></name><name name-style="western"><surname>Berry</surname><given-names>SA</given-names></name></person-group>
          <year>1992</year>
          <article-title>Cockayne syndrome: Review of 140 cases.</article-title>
          <source>Am J Med Genet</source>
          <volume>42</volume>
          <fpage>68</fpage>
          <lpage>84</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b014">
        <label>14</label>
        <element-citation publication-type="other" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Bootsma</surname><given-names>D</given-names></name><name name-style="western"><surname>Kraemer</surname><given-names>KH</given-names></name><name name-style="western"><surname>J.E</surname><given-names>C</given-names></name><name name-style="western"><surname>Hoeijmakers</surname><given-names>J</given-names></name></person-group>
          <year>2002</year>
          <source>Nucleotide excision repair syndromes: Xeroderma Pigmentosum, Cockayne Syndrome and
            trichthiodystrophy</source>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>McGraw-Hill Medical Publishing Division</publisher-name>
          <fpage>211</fpage>
          <lpage>237</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b015">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Vermeulen</surname><given-names>W</given-names></name><name name-style="western"><surname>Rademakers</surname><given-names>S</given-names></name><name name-style="western"><surname>Jaspers</surname><given-names>NG</given-names></name><name name-style="western"><surname>Appeldoorn</surname><given-names>E</given-names></name><name name-style="western"><surname>Raams</surname><given-names>A</given-names></name><etal/></person-group>
          <year>2001</year>
          <article-title>A temperature-sensitive disorder in basal transcription and DNA repair in
            humans.</article-title>
          <source>Nat Genet</source>
          <volume>27</volume>
          <fpage>299</fpage>
          <lpage>303</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b016">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>van der Horst</surname><given-names>GT</given-names></name><name name-style="western"><surname>van Steeg</surname><given-names>H</given-names></name><name name-style="western"><surname>Berg</surname><given-names>RJ</given-names></name><name name-style="western"><surname>van Gool</surname><given-names>AJ</given-names></name><name name-style="western"><surname>de Wit</surname><given-names>J</given-names></name><etal/></person-group>
          <year>1997</year>
          <article-title>Defective transcription-coupled repair in Cockayne syndrome B mice is
            associated with skin cancer predisposition.</article-title>
          <source>Cell</source>
          <volume>89</volume>
          <fpage>425</fpage>
          <lpage>435</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b017">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>van der Horst</surname><given-names>GT</given-names></name><name name-style="western"><surname>Meira</surname><given-names>L</given-names></name><name name-style="western"><surname>Gorgels</surname><given-names>TG</given-names></name><name name-style="western"><surname>de Wit</surname><given-names>J</given-names></name><name name-style="western"><surname>Velasco-Miguel</surname><given-names>S</given-names></name><etal/></person-group>
          <year>2002</year>
          <article-title>UVB radiation-induced cancer predisposition in Cockayne syndrome group A
              (<italic>Csa</italic>) mutant mice.</article-title>
          <source>DNA Repair (Amst)</source>
          <volume>1</volume>
          <fpage>143</fpage>
          <lpage>157</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b018">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Hasty</surname><given-names>P</given-names></name><name name-style="western"><surname>Campisi</surname><given-names>J</given-names></name><name name-style="western"><surname>Hoeijmakers</surname><given-names>J</given-names></name><name name-style="western"><surname>van Steeg</surname><given-names>H</given-names></name><name name-style="western"><surname>Vijg</surname><given-names>J</given-names></name></person-group>
          <year>2003</year>
          <article-title>Aging and genome maintenance: Lessons from the mouse?</article-title>
          <source>Science</source>
          <volume>299</volume>
          <fpage>1355</fpage>
          <lpage>1359</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b019">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>de Boer</surname><given-names>J</given-names></name><name name-style="western"><surname>Hoeijmakers</surname><given-names>JH</given-names></name></person-group>
          <year>2000</year>
          <article-title>Nucleotide excision repair and human syndromes.</article-title>
          <source>Carcinogenesis</source>
          <volume>21</volume>
          <fpage>453</fpage>
          <lpage>460</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b020">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>JR</given-names></name><name name-style="western"><surname>Hoeijmakers</surname><given-names>JH</given-names></name><name name-style="western"><surname>Niedernhofer</surname><given-names>LJ</given-names></name></person-group>
          <year>2003</year>
          <article-title>Divide and conquer: Nucleotide excision repair battles cancer and ageing.</article-title>
          <source>Curr Opin Cell Biol</source>
          <volume>15</volume>
          <fpage>232</fpage>
          <lpage>240</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b021">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Cheo</surname><given-names>DL</given-names></name><name name-style="western"><surname>Ruven</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Meira</surname><given-names>LB</given-names></name><name name-style="western"><surname>Hammer</surname><given-names>RE</given-names></name><name name-style="western"><surname>Burns</surname><given-names>DK</given-names></name><etal/></person-group>
          <year>1997</year>
          <article-title>Characterization of defective nucleotide excision repair in XPC mutant
            mice.</article-title>
          <source>Mutat Res</source>
          <volume>374</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b022">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>de Vries</surname><given-names>A</given-names></name><name name-style="western"><surname>van Oostrom</surname><given-names>CT</given-names></name><name name-style="western"><surname>Hofhuis</surname><given-names>FM</given-names></name><name name-style="western"><surname>Dortant</surname><given-names>PM</given-names></name><name name-style="western"><surname>Berg</surname><given-names>RJ</given-names></name><etal/></person-group>
          <year>1995</year>
          <article-title>Increased susceptibility to ultraviolet-B and carcinogens of mice lacking
            the DNA excision repair gene XPA.</article-title>
          <source>Nature</source>
          <volume>377</volume>
          <fpage>169</fpage>
          <lpage>173</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b023">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Parrinello</surname><given-names>S</given-names></name><name name-style="western"><surname>Samper</surname><given-names>E</given-names></name><name name-style="western"><surname>Krtolica</surname><given-names>A</given-names></name><name name-style="western"><surname>Goldstein</surname><given-names>J</given-names></name><name name-style="western"><surname>Melov</surname><given-names>S</given-names></name><etal/></person-group>
          <year>2003</year>
          <article-title>Oxygen sensitivity severely limits the replicative lifespan of murine
            fibroblasts.</article-title>
          <source>Nat Cell Biol</source>
          <volume>5</volume>
          <fpage>741</fpage>
          <lpage>747</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b024">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Busuttil</surname><given-names>RA</given-names></name><name name-style="western"><surname>Rubio</surname><given-names>M</given-names></name><name name-style="western"><surname>Dolle</surname><given-names>ME</given-names></name><name name-style="western"><surname>Campisi</surname><given-names>J</given-names></name><name name-style="western"><surname>Vijg</surname><given-names>J</given-names></name></person-group>
          <year>2003</year>
          <article-title>Oxygen accelerates the accumulation of mutations during the senescence and
            immortalization of murine cells in culture.</article-title>
          <source>Aging Cell</source>
          <volume>2</volume>
          <fpage>287</fpage>
          <lpage>294</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b025">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Murai</surname><given-names>M</given-names></name><name name-style="western"><surname>Enokido</surname><given-names>Y</given-names></name><name name-style="western"><surname>Inamura</surname><given-names>N</given-names></name><name name-style="western"><surname>Yoshino</surname><given-names>M</given-names></name><name name-style="western"><surname>Nakatsu</surname><given-names>Y</given-names></name><etal/></person-group>
          <year>2001</year>
          <article-title>Early postnatal ataxia and abnormal cerebellar development in mice lacking
            Xeroderma pigmentosum Group A and Cockayne syndrome Group B DNA repair genes.</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <volume>98</volume>
          <fpage>13379</fpage>
          <lpage>13384</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b026">
        <label>26</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Itoh</surname><given-names>M</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>M</given-names></name><name name-style="western"><surname>Shioda</surname><given-names>K</given-names></name><name name-style="western"><surname>Minagawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Isa</surname><given-names>F</given-names></name><etal/></person-group>
          <year>1999</year>
          <article-title>Neurodegeneration in hereditary nucleotide repair disorders.</article-title>
          <source>Brain Dev</source>
          <volume>21</volume>
          <fpage>326</fpage>
          <lpage>333</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b027">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Traboulsi</surname><given-names>EI</given-names></name><name name-style="western"><surname>De Becker</surname><given-names>I</given-names></name><name name-style="western"><surname>Maumenee</surname><given-names>IH</given-names></name></person-group>
          <year>1992</year>
          <article-title>Ocular findings in Cockayne syndrome.</article-title>
          <source>Am J Ophthalmol</source>
          <volume>114</volume>
          <fpage>579</fpage>
          <lpage>583</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b028">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>McCarroll</surname><given-names>SA</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>CT</given-names></name><name name-style="western"><surname>Zou</surname><given-names>S</given-names></name><name name-style="western"><surname>Pletcher</surname><given-names>SD</given-names></name><name name-style="western"><surname>Chin</surname><given-names>CS</given-names></name><etal/></person-group>
          <year>2004</year>
          <article-title>Comparing genomic expression patterns across species identifies shared
            transcriptional profile in aging.</article-title>
          <source>Nat Genet</source>
          <volume>36</volume>
          <fpage>197</fpage>
          <lpage>204</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b029">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Fraser</surname><given-names>HB</given-names></name><name name-style="western"><surname>Khaitovich</surname><given-names>P</given-names></name><name name-style="western"><surname>Plotkin</surname><given-names>JB</given-names></name><name name-style="western"><surname>Paabo</surname><given-names>S</given-names></name><name name-style="western"><surname>Eisen</surname><given-names>MB</given-names></name></person-group>
          <year>2005</year>
          <article-title>Aging and gene expression in the primate brain.</article-title>
          <source>PLoS Biol</source>
          <volume>3</volume>
          <issue>(9)</issue>
          <elocation-id>e274.</elocation-id>
          <comment>doi:<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pbio.0030274" xlink:type="simple">10.1371/journal.pbio.0030274</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b030">
        <label>30</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Frystyk</surname><given-names>J</given-names></name></person-group>
          <year>2004</year>
          <article-title>Free insulin-like growth factors—measurements and relationships
            to growth hormone secretion and glucose homeostasis.</article-title>
          <source>Growth Horm IGF Res</source>
          <volume>14</volume>
          <fpage>337</fpage>
          <lpage>375</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b031">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Ahima</surname><given-names>R</given-names></name><name name-style="western"><surname>Osei</surname><given-names>SY</given-names></name></person-group>
          <year>2004</year>
          <article-title>Leptin and appetite control in lipodystrophy.</article-title>
          <source>J Clin Endocrinol Metab</source>
          <volume>89</volume>
          <fpage>4254</fpage>
          <lpage>4257</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b032">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Seth</surname><given-names>PK</given-names></name></person-group>
          <year>1982</year>
          <article-title>Hepatic effects of phthalate esters.</article-title>
          <source>Environ Health Perspect</source>
          <volume>45</volume>
          <fpage>27</fpage>
          <lpage>34</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b033">
        <label>33</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Horibata</surname><given-names>K</given-names></name><name name-style="western"><surname>Iwamoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kuraoka</surname><given-names>I</given-names></name><name name-style="western"><surname>Jaspers</surname><given-names>NG</given-names></name><name name-style="western"><surname>Kurimasa</surname><given-names>A</given-names></name><etal/></person-group>
          <year>2004</year>
          <article-title>Complete absence of Cockayne syndrome group B gene product gives rise to
            UV-sensitive syndrome but not Cockayne syndrome.</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <volume>101</volume>
          <fpage>15410</fpage>
          <lpage>15415</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b034">
        <label>34</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Andressoo</surname><given-names>JO</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>JR</given-names></name><name name-style="western"><surname>de Wit</surname><given-names>J</given-names></name><name name-style="western"><surname>Hoogstraten</surname><given-names>D</given-names></name><name name-style="western"><surname>Volker</surname><given-names>M</given-names></name><etal/></person-group>
          <year>2006</year>
          <article-title>An <italic>Xpd</italic> mouse model for the combined xeroderma
            pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental
            progeria.</article-title>
          <source>Cancer Cell</source>
          <volume>10</volume>
          <fpage>121</fpage>
          <lpage>132</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b035">
        <label>35</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>van de Ven</surname><given-names>M</given-names></name><name name-style="western"><surname>Andressoo</surname><given-names>JO</given-names></name><name name-style="western"><surname>Holcomb</surname><given-names>VB</given-names></name><name name-style="western"><surname>von Lindern</surname><given-names>M</given-names></name><name name-style="western"><surname>Jong</surname><given-names>W</given-names></name><etal/></person-group>
          <year>2006</year>
          <article-title>Adaptive stress response in segmental progeria resembles long-lived
            dwarfism and calorie restriction in mice.</article-title>
          <source>PLoS Genet</source>
          <comment>E-pub 2 October 2006.</comment>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b036">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Shiomi</surname><given-names>N</given-names></name><name name-style="western"><surname>Mori</surname><given-names>M</given-names></name><name name-style="western"><surname>Kito</surname><given-names>S</given-names></name><name name-style="western"><surname>Harada</surname><given-names>YN</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>K</given-names></name><etal/></person-group>
          <year>2005</year>
          <article-title>Severe growth retardation and short life span of double-mutant mice lacking
            Xpa and exon 15 of Xpg.</article-title>
          <source>DNA Repair (Amst)</source>
          <volume>4</volume>
          <fpage>351</fpage>
          <lpage>357</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b037">
        <label>37</label>
        <element-citation publication-type="other" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Arking</surname><given-names>R</given-names></name></person-group>
          <year>1998</year>
          <source>Biology of aging; Observations and principles</source>
          <publisher-loc>Sunderland (Massachusetts)</publisher-loc>
          <publisher-name>Sinauer Associates</publisher-name>
          <!--===== Restructure page-count as size[@units="page"] =====--><size units="page">528</size>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b038">
        <label>38</label>
        <element-citation publication-type="other" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Kalu</surname><given-names>DN</given-names></name></person-group>
          <year>1995</year>
          <article-title>Bone.</article-title>
          <comment>In:</comment>
          <person-group person-group-type="editor"><name name-style="western"><surname>Masoro</surname></name></person-group>
          <source>Handbook of physiology of aging</source>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Oxford University Press</publisher-name>
          <fpage>395</fpage>
          <lpage>411</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b039">
        <label>39</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>A</given-names></name><name name-style="western"><surname>Arbell</surname><given-names>I</given-names></name><name name-style="western"><surname>Steinhagen-Thiessen</surname><given-names>E</given-names></name><name name-style="western"><surname>Silbermann</surname><given-names>M</given-names></name></person-group>
          <year>1991</year>
          <article-title>Structural changes in aging bone: Osteopenia in the proximal femurs of
            female mice.</article-title>
          <source>Bone</source>
          <volume>12</volume>
          <fpage>165</fpage>
          <lpage>172</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b040">
        <label>40</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>CS</given-names></name><name name-style="western"><surname>Ramsey</surname><given-names>MM</given-names></name><name name-style="western"><surname>Sonntag</surname><given-names>WE</given-names></name></person-group>
          <year>2002</year>
          <article-title>A critical analysis of the role of growth hormone and IGF-1 in aging and
            lifespan.</article-title>
          <source>Trends Genet</source>
          <volume>18</volume>
          <fpage>295</fpage>
          <lpage>301</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b041">
        <label>41</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Puigserver</surname><given-names>P</given-names></name><name name-style="western"><surname>Rhee</surname><given-names>J</given-names></name><name name-style="western"><surname>Donovan</surname><given-names>J</given-names></name><name name-style="western"><surname>Walkey</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>JC</given-names></name><etal/></person-group>
          <year>2003</year>
          <article-title>Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha
            interaction.</article-title>
          <source>Nature</source>
          <volume>423</volume>
          <fpage>550</fpage>
          <lpage>555</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b042">
        <label>42</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Longo</surname><given-names>VD</given-names></name><name name-style="western"><surname>Finch</surname><given-names>CE</given-names></name></person-group>
          <year>2003</year>
          <article-title>Evolutionary medicine: From dwarf model systems to healthy centenarians?</article-title>
          <source>Science</source>
          <volume>299</volume>
          <fpage>1342</fpage>
          <lpage>1346</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b043">
        <label>43</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>SK</given-names></name><name name-style="western"><surname>Chang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Cho</surname><given-names>SB</given-names></name><name name-style="western"><surname>Baek</surname><given-names>HS</given-names></name><name name-style="western"><surname>Lee</surname><given-names>DY</given-names></name></person-group>
          <year>1994</year>
          <article-title>Cockayne syndrome: A case with hyperinsulinemia and growth hormone
            deficiency.</article-title>
          <source>J Korean Med Sci</source>
          <volume>9</volume>
          <fpage>74</fpage>
          <lpage>77</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b044">
        <label>44</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Fujimoto</surname><given-names>WY</given-names></name><name name-style="western"><surname>Green</surname><given-names>ML</given-names></name><name name-style="western"><surname>Seegmiller</surname><given-names>JE</given-names></name></person-group>
          <year>1969</year>
          <article-title>Cockayne's syndrome: Report of a case with hyperlipoproteinemia,
            hyperinsulinemia, renal disease, and normal growth hormone.</article-title>
          <source>J Pediatr</source>
          <volume>75</volume>
          <fpage>881</fpage>
          <lpage>884</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b045">
        <label>45</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Ellaway</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Duggins</surname><given-names>A</given-names></name><name name-style="western"><surname>Fung</surname><given-names>VS</given-names></name><name name-style="western"><surname>Earl</surname><given-names>JW</given-names></name><name name-style="western"><surname>Kamath</surname><given-names>R</given-names></name><etal/></person-group>
          <year>2000</year>
          <article-title>Cockayne syndrome associated with low CSF 5-hydroxyindole acetic acid
            levels.</article-title>
          <source>J Med Genet</source>
          <volume>37</volume>
          <fpage>553</fpage>
          <lpage>557</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b046">
        <label>46</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Laszlo</surname><given-names>A</given-names></name><name name-style="western"><surname>Simon</surname><given-names>M</given-names></name></person-group>
          <year>1986</year>
          <article-title>Serum lipid and lipoprotein levels in premature ageing syndromes: Total
            lipodystrophy and Cockayne syndrome.</article-title>
          <source>Arch Gerontol Geriatr</source>
          <volume>5</volume>
          <fpage>189</fpage>
          <lpage>196</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b047">
        <label>47</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Kenyon</surname><given-names>C</given-names></name></person-group>
          <year>2005</year>
          <article-title>The plasticity of aging: Insights from long-lived mutants.</article-title>
          <source>Cell</source>
          <volume>120</volume>
          <fpage>449</fpage>
          <lpage>460</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b048">
        <label>48</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Partridge</surname><given-names>L</given-names></name><name name-style="western"><surname>Gems</surname><given-names>D</given-names></name><name name-style="western"><surname>Withers</surname><given-names>DJ</given-names></name></person-group>
          <year>2005</year>
          <article-title>Sex and death: What is the connection?</article-title>
          <source>Cell</source>
          <volume>120</volume>
          <fpage>461</fpage>
          <lpage>472</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b049">
        <label>49</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Brown-Borg</surname><given-names>HM</given-names></name><name name-style="western"><surname>Bode</surname><given-names>AM</given-names></name><name name-style="western"><surname>Bartke</surname><given-names>A</given-names></name></person-group>
          <year>1999</year>
          <article-title>Antioxidative mechanisms and plasma growth hormone levels: Potential
            relationship in the aging process.</article-title>
          <source>Endocrine</source>
          <volume>11</volume>
          <fpage>41</fpage>
          <lpage>48</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b050">
        <label>50</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Brown-Borg</surname><given-names>HM</given-names></name><name name-style="western"><surname>Rakoczy</surname><given-names>SG</given-names></name></person-group>
          <year>2000</year>
          <article-title>Catalase expression in delayed and premature aging mouse models.</article-title>
          <source>Exp Gerontol</source>
          <volume>35</volume>
          <fpage>199</fpage>
          <lpage>212</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b051">
        <label>51</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Bartke</surname><given-names>A</given-names></name><name name-style="western"><surname>Chandrashekar</surname><given-names>V</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>B</given-names></name><name name-style="western"><surname>Zaczek</surname><given-names>D</given-names></name><name name-style="western"><surname>Turyn</surname><given-names>D</given-names></name></person-group>
          <year>2002</year>
          <article-title>Consequences of growth hormone (GH) overexpression and GH resistance.</article-title>
          <source>Neuropeptides</source>
          <volume>36</volume>
          <fpage>201</fpage>
          <lpage>208</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b052">
        <label>52</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Florini</surname><given-names>JR</given-names></name><name name-style="western"><surname>Harned</surname><given-names>JA</given-names></name><name name-style="western"><surname>Richman</surname><given-names>RA</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>JP</given-names></name></person-group>
          <year>1981</year>
          <article-title>Effect of rat age on serum levels of growth hormone and somatomedins.</article-title>
          <source>Mech Ageing Dev</source>
          <volume>15</volume>
          <fpage>165</fpage>
          <lpage>176</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b053">
        <label>53</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Johanson</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Blizzard</surname><given-names>RM</given-names></name></person-group>
          <year>1981</year>
          <article-title>Low somatomedin-C levels in older men rise in response to growth hormone
            administration.</article-title>
          <source>Johns Hopkins Med J</source>
          <volume>149</volume>
          <fpage>115</fpage>
          <lpage>117</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b054">
        <label>54</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Rudman</surname><given-names>D</given-names></name><name name-style="western"><surname>Kutner</surname><given-names>MH</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>CM</given-names></name><name name-style="western"><surname>Lubin</surname><given-names>MF</given-names></name><name name-style="western"><surname>Fleming</surname><given-names>GA</given-names></name><etal/></person-group>
          <year>1981</year>
          <article-title>Impaired growth hormone secretion in the adult population: relation to age
            and adiposity.</article-title>
          <source>J Clin Invest</source>
          <volume>67</volume>
          <fpage>1361</fpage>
          <lpage>1369</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b055">
        <label>55</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Camougrand</surname><given-names>N</given-names></name><name name-style="western"><surname>Rigoulet</surname><given-names>M</given-names></name></person-group>
          <year>2001</year>
          <article-title>Aging and oxidative stress: Studies of some genes involved both in aging
            and in response to oxidative stress.</article-title>
          <source>Respir Physiol</source>
          <volume>128</volume>
          <fpage>393</fpage>
          <lpage>401</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b056">
        <label>56</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Ji</surname><given-names>LL</given-names></name><name name-style="western"><surname>Leeuwenburgh</surname><given-names>C</given-names></name><name name-style="western"><surname>Leichtweis</surname><given-names>S</given-names></name><name name-style="western"><surname>Gore</surname><given-names>M</given-names></name><name name-style="western"><surname>Fiebig</surname><given-names>R</given-names></name><etal/></person-group>
          <year>1998</year>
          <article-title>Oxidative stress and aging. Role of exercise and its influences on
            antioxidant systems.</article-title>
          <source>Ann N Y Acad Sci</source>
          <volume>854</volume>
          <fpage>102</fpage>
          <lpage>117</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b057">
        <label>57</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Bartke</surname><given-names>A</given-names></name></person-group>
          <year>2003</year>
          <article-title>Is growth hormone deficiency a beneficial adaptation to aging? Evidence
            from experimental animals.</article-title>
          <source>Trends Endocrinol Metab</source>
          <volume>14</volume>
          <fpage>340</fpage>
          <lpage>344</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b058">
        <label>58</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Chandrashekar</surname><given-names>V</given-names></name><name name-style="western"><surname>Zaczek</surname><given-names>D</given-names></name><name name-style="western"><surname>Bartke</surname><given-names>A</given-names></name></person-group>
          <year>2004</year>
          <article-title>The consequences of altered somatotropic system on reproduction.</article-title>
          <source>Biol Reprod</source>
          <volume>71</volume>
          <fpage>17</fpage>
          <lpage>27</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b059">
        <label>59</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Beckman</surname><given-names>KB</given-names></name><name name-style="western"><surname>Ames</surname><given-names>BN</given-names></name></person-group>
          <year>1998</year>
          <article-title>The free radical theory of aging matures.</article-title>
          <source>Physiol Rev</source>
          <volume>78</volume>
          <fpage>547</fpage>
          <lpage>581</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b060">
        <label>60</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>de Waard</surname><given-names>H</given-names></name><name name-style="western"><surname>de Wit</surname><given-names>J</given-names></name><name name-style="western"><surname>Andressoo</surname><given-names>JO</given-names></name><name name-style="western"><surname>van Oostrom</surname><given-names>CTM</given-names></name><name name-style="western"><surname>Riis</surname><given-names>B</given-names></name><etal/></person-group>
          <year>2003</year>
          <article-title>Different effects of CSA and CSB deficiency on sensitivity to oxidative DNA
            damage.</article-title>
          <source>Mol Cell Biol</source>
          <volume>24</volume>
          <fpage>7941</fpage>
          <lpage>7948</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b061">
        <label>61</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Hirosawa</surname><given-names>N</given-names></name><name name-style="western"><surname>Yano</surname><given-names>K</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sakamoto</surname><given-names>Y</given-names></name></person-group>
          <year>2006</year>
          <article-title>Endocrine disrupting effect of di-(2-ethylhexyl)phthalate on female rats
            and proteome analyses of their pituitaries.</article-title>
          <source>Proteomics</source>
          <volume>6</volume>
          <fpage>958</fpage>
          <lpage>971</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b062">
        <label>62</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Harada</surname><given-names>YN</given-names></name><name name-style="western"><surname>Shiomi</surname><given-names>N</given-names></name><name name-style="western"><surname>Koike</surname><given-names>M</given-names></name><name name-style="western"><surname>Ikawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Okabe</surname><given-names>M</given-names></name><etal/></person-group>
          <year>1999</year>
          <article-title>Postnatal growth failure, short life span, and early onset of cellular
            senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum
            group G gene.</article-title>
          <source>Mol Cell Biol</source>
          <volume>19</volume>
          <fpage>2366</fpage>
          <lpage>2372</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b063">
        <label>63</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>M</given-names></name><name name-style="western"><surname>Shinkura</surname><given-names>R</given-names></name><name name-style="western"><surname>Shinkura</surname><given-names>N</given-names></name><name name-style="western"><surname>Alt</surname><given-names>FW</given-names></name></person-group>
          <year>2004</year>
          <article-title>Growth retardation, early death, and DNA repair defects in mice deficient
            for the nucleotide excision repair enzyme XPF.</article-title>
          <source>Mol Cell Biol</source>
          <volume>24</volume>
          <fpage>1200</fpage>
          <lpage>1205</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b064">
        <label>64</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Wijnhoven</surname><given-names>SW</given-names></name><name name-style="western"><surname>Beems</surname><given-names>RB</given-names></name><name name-style="western"><surname>Roodbergen</surname><given-names>M</given-names></name><name name-style="western"><surname>van den Berg</surname><given-names>J</given-names></name><name name-style="western"><surname>Lohman</surname><given-names>PH</given-names></name><etal/></person-group>
          <year>2005</year>
          <article-title>Accelerated aging pathology in ad libitum fed <italic>Xpd</italic>(TTD)
            mice is accompanied by features suggestive of caloric restriction.</article-title>
          <source>DNA Repair (Amst)</source>
          <volume>4</volume>
          <fpage>1314</fpage>
          <lpage>1324</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b065">
        <label>65</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Mostoslavsky</surname><given-names>R</given-names></name><name name-style="western"><surname>Chua</surname><given-names>KF</given-names></name><name name-style="western"><surname>Lombard</surname><given-names>DB</given-names></name><name name-style="western"><surname>Pang</surname><given-names>WW</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>MR</given-names></name><etal/></person-group>
          <year>2006</year>
          <article-title>Genomic instability and aging-like phenotype in the absence of mammalian
            SIRT6.</article-title>
          <source>Cell</source>
          <volume>124</volume>
          <fpage>315</fpage>
          <lpage>329</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b066">
        <label>66</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Cheo</surname><given-names>DL</given-names></name><name name-style="western"><surname>Meira</surname><given-names>LB</given-names></name><name name-style="western"><surname>Hammer</surname><given-names>RE</given-names></name><name name-style="western"><surname>Burns</surname><given-names>DK</given-names></name><name name-style="western"><surname>Doughty</surname><given-names>AT</given-names></name><etal/></person-group>
          <year>1996</year>
          <article-title>Synergistic interactions between XPC and p53 mutations in double-mutant
            mice: Neural tube abnormalities and accelerated UV radiation-induced skin cancer.</article-title>
          <source>Curr Biol</source>
          <volume>6</volume>
          <fpage>1691</fpage>
          <lpage>1694</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b067">
        <label>67</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Nakane</surname><given-names>H</given-names></name><name name-style="western"><surname>Takeuchi</surname><given-names>S</given-names></name><name name-style="western"><surname>Yuba</surname><given-names>S</given-names></name><name name-style="western"><surname>Saijo</surname><given-names>M</given-names></name><name name-style="western"><surname>Nakatsu</surname><given-names>Y</given-names></name><etal/></person-group>
          <year>1995</year>
          <article-title>High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours
            in mice lacking the xeroderma pigmentosum group A gene.</article-title>
          <source>Nature</source>
          <volume>377</volume>
          <fpage>165</fpage>
          <lpage>168</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b068">
        <label>68</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Lowe</surname><given-names>SW</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>EM</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SW</given-names></name><name name-style="western"><surname>Osborne</surname><given-names>BA</given-names></name><name name-style="western"><surname>Jacks</surname><given-names>T</given-names></name></person-group>
          <year>1993</year>
          <article-title>p53 is required for radiation-induced apoptosis in mouse thymocytes.</article-title>
          <source>Nature</source>
          <volume>362</volume>
          <fpage>847</fpage>
          <lpage>849</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b069">
        <label>69</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Sijbers</surname><given-names>AM</given-names></name><name name-style="western"><surname>de Laat</surname><given-names>WL</given-names></name><name name-style="western"><surname>Ariza</surname><given-names>RR</given-names></name><name name-style="western"><surname>Biggerstaff</surname><given-names>M</given-names></name><name name-style="western"><surname>Wei</surname><given-names>YF</given-names></name><etal/></person-group>
          <year>1996</year>
          <article-title>Xeroderma pigmentosum group F caused by a defect in a structure-specific
            DNA repair endonuclease.</article-title>
          <source>Cell</source>
          <volume>86</volume>
          <fpage>811</fpage>
          <lpage>822</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b070">
        <label>70</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Vermeulen</surname><given-names>W</given-names></name><name name-style="western"><surname>Scott</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Rodgers</surname><given-names>S</given-names></name><name name-style="western"><surname>Muller</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Cole</surname><given-names>J</given-names></name><etal/></person-group>
          <year>1994</year>
          <article-title>Clinical heterogeneity within xeroderma pigmentosum associated with
            mutations in the DNA repair and transcription gene ERCC3.</article-title>
          <source>Am J Hum Genet</source>
          <volume>54</volume>
          <fpage>191</fpage>
          <lpage>200</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b071">
        <label>71</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>GT</given-names></name><name name-style="western"><surname>Roth</surname><given-names>ME</given-names></name><name name-style="western"><surname>Groskopf</surname><given-names>JC</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>FY</given-names></name><name name-style="western"><surname>Orkin</surname><given-names>SH</given-names></name><etal/></person-group>
          <year>1997</year>
          <article-title>GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo.</article-title>
          <source>Development</source>
          <volume>124</volume>
          <fpage>907</fpage>
          <lpage>914</lpage>
        </element-citation>
      </ref>
      <ref id="pbio-0050002-b072">
        <label>72</label>
        <element-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Lione</surname><given-names>LA</given-names></name><name name-style="western"><surname>Humby</surname><given-names>T</given-names></name><name name-style="western"><surname>Mangiarini</surname><given-names>L</given-names></name><name name-style="western"><surname>Mahal</surname><given-names>A</given-names></name><etal/></person-group>
          <year>1999</year>
          <article-title>Characterization of progressive motor deficits in mice transgenic for the
            human Huntington's disease mutation.</article-title>
          <source>J Neurosci</source>
          <volume>19</volume>
          <fpage>3248</fpage>
          <lpage>3257</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>